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ABSTRACT

Yuezhi Du. Ph.D., Purdue University, December 2015 Signal enhancement and data
mining for biological and chemical analysis using mass spectrometry. Major Professor:
Zheng Ouyang.
Mass spectrometry has been actively involved in the areas of healthcare,
pharmaceutics, environmental analysis, food industry and forensics due to its ability to
provide molecular information at trace levels. Recently, because of the complexity of
chemical and biological samples, computer-assisted mass spectra analysis, including signal
enhancement, statistics and machine learning, has been drawn more and more attention
especially for researches in biomarker identification, sample classification and omicsrelated areas where high volume of data is generated.
Typically, mass spectra analysis follows two steps. Firstly, signal enhancement is
performed to systematically filter out the background noise and enhance the detected
signals. Secondly, data mining is used to extract the meaningful signals in the mass spectra.
Depending on the mechanisms of mass spectrometry and nature of samples, different
methods in signal enhancement and data mining are developed to address the needs.
Image current measurement followed by Fourier transform is a non-destructive mass
analysis method and has been widely used for Fourier transform ion cyclotron resonance,
Orbitrap mass spectrometers and recently quadrupole ion traps. The phase between the ion
excitation and the image current measurement typically needs to be well controlled

xiv
for obtaining high quality spectra. In this thesis, a data processing method based on selfcorrelation (SC) function has been explored for signal enhancement with image current
data recorded at random phases. The simple algorithm of the SC method was introduced
and a series of data used for demonstrations was simulated based on a previous study on
non-destructive mass analysis using an ion trap. A significant improvement has been
achieved in the signal-to-noise ratio (SNR) as well as in the accuracy of the peak ratio.
The efficiency of using a mask data set for selected ion monitoring has also been
demonstrated.
In recent researches in chemical and biological studies, biomarker profiling using
mass spectrometry plays an essential role in biological studies and is high dependent on
the data analysis for sample classification. In this thesis, power normalization of the mass
spectra has been proposed as a method of altering the weights of peaks at different intensity
levels. In combination of the supporting vector machine method, its impact on the sample
classification has been characterized using the data in four studies previously reported for
distinguishing anomeric configurations of sugars, types of bacteria, stages of melanoma
and types of breast cancer. Comprehensive analysis of the data with normalization at
different power normalization index (PNI) was developed with analysis tools, including
error-PNI plots, reference profiles and error source profiles, to assess the analytical method
as well as to find the proper approach to classify the samples involved in the study.

1

CHAPTER 1.! INTRODUCTION

Mass spectrometry has been actively involved in the areas of healthcare,1-3
pharmaceutics,4-6 environmental analysis,7,8 food industry9-11 and forensics12,13 due to its
ability to provide molecular information at trace levels. With the booming of electronics
and computers as well as simplified operations in sample preparation, huge quantities of
mass spectra with highly detailed information have been constantly generated in recent
decades, especially in the health care and omics-related fields.14,15 Accordingly, computerassisted analysis has been developed to help scientists in understanding the mass spectra
instead of the visual-based interpretation.16-18 As a result, the informatics and data science
in mass spectrometry, including data processing, statistics, algorithm design and machine
learning, have drawn more and more attention.

1.1! Mass spectra collection and mass spectrometry
Mass spectrometry consists of an ion source, a mass analyzer and a detector (Figure
1.1). Sequentially, molecules in a sample are first ionized by ion sources such as electron
ionization (EI),19,20 electrospray ionization (ESI),21,22 low temperature plasma desorption
(LTP),23 matrix-assisted laser desorption ionization (MALDI)24 and paper spray ionization
(PSI).25,26 The general ionization formula is described below.
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M + e− → M i+ + 2e−

Equation 1.1

M + RH → MH + + R −

food$

"""Rela-ve"Intensity"""""

where M is the molecule in a sample and H is a proton.

,ssue$sec,on$

Sample'
explosives$

Sample'
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drugs$

…"etc."
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Mass'
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m/z"
Mass'
Spectrum'

Figure 1.1 Work flow of sample analysis using mass spectrometry.
Then, generated ions are transferred and separated into mass analyzers based on massover-charge ratio (m/z). In detail, different mass analyzers have different mechanisms to
analyze ions. For example, quadrupole and ion trap analyzers separate ions mostly by
boundary ejection based on the stability diagram, while Fourier transform mass
spectrometry detects ions based on the difference of characteristic secular frequencies;
additionally the Time-of-flight mass analyzer distinguishes ions based on the drifting
velocity of accelerating ions with different charge and mass. During researches requiring
mass spectrometry, those mass analyzers are chosen based on the experimental conditions
and sample properties.
At last, desired ions are recorded in the detector and displayed by computer. The result
appears as a spectrum with the X axis representing m/z ratio and the Y axis representing
relative intensity. As an example, mass spectra of C20H42 and C100H202 have been shown in
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Figure 2.2, where the monoisotopic mass is 282 and 1403 for alkanes with 20 and 100
carbon atoms, respectively.27 Constitutional isomers, which are molecules with the same
m/z ratios, can further be identified by tandem MS. During this process, energy applied to
the molecule induces bond cleavage and generates charged fragments, which are unique
for different structures due to bond energy difference.

(a)$

(b)$

Figure 1.2 Theoretical mass spectrum with isotopic distribution of (a) C20H42 and (b)
C100H202.
Mass spectra contain the information both of the type of molecules in a sample, which
is shown as peaks on specific m/z positions, and the relative concentration of that molecule
compared to the others, which is shown as intensity of the peaks. In order to quantify the
concentration precisely, an internal standard, which is usually the isotope-labeled molecule
or other similarly structured molecules with known concentration, is added to the sample.
Then, the intensity ratio of the detected molecule and internal standard are analyzed to
determine the precise concentration in the drug. This precision is important in situations
such as the analysis of abusive drug metabolites remains in blood.28
Peaks intensities are affected tremendously by experimental parameters. For example,
the slight difference in heating temperature, spray voltage, collision energy, etc. may result
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in different dominant peaks due to the efficiency and stability of ionization, desolvation,
fragmentation and so on (Figure 1.3). Thus, those parameters have to be carefully tuned
to obtain the desired mass spectra. Even with the same parameters, the instrument
conditions such as electronic interference, environment conditions such as moisture level
vacuum levels, and labor difference may also introduce variance into the mass spectra.

(a)$

(b)$

(c)$

Figure 1.3 Isolation of two peaks m/z 221 and m/z 223 from 18O-labeled β-D-Glcp-(1-3)D-Glc at collision energy (a) 5V (b) 10V and (c) 15Vin Ion trap mass spectrometry.29
Another source of interference is the matrix effect, which is the combined effect of
molecular components of a sample other than the analyte of interest. The matrix effect
gives rise to a large number of peaks in mass spectra. Unlike the variance from the
instrument conditions discussed above, matrix effects are truly existing molecules in the
mass spectrometry, which cannot be averaged to be eliminated. For example, in the
analysis of lipid profiles of the bacteria cell membrane, the molecules from growth media
constantly cover the mass range of m/z 50 to 250. Another frequently used sample, blood,
also has a variety of molecules, which usually have dominant intensity compared to the
desired analyte in the mass spectra.28,30 Thus, finding characteristic peaks of the analyte
and recovering them with desired resolution from variance and matrix effect are highly
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required, especially when using the high-resolution mass spectrometry, where high
volumes of data are collected.

(b)$100

SAR$A50$

Rela1ve$Intensity$

100

Rela1ve$Intensity$

(a)$

50

0
50

100

150

m/z$

200

250

300

SAR$A51$

50

0
50

100

150

m/z$

200

250

300

Figure 1.4 Mass spectra of bacteria (a)SAR A50 and (b) SAR A51. The blue square is the
range of matrix effect from growth media Luria-Ber- tani agar.31

1.2! Data analysis in mass spectra
The mass spectra analysis is based on the position and intensity of the peaks when
high volume of data is generated with noise and matrix effect. Thus, the procedure of
filtering out irrelevant peaks, calibrating peak position and intensities, and enhancing
meaningful signals is of paramount importance. Based on the different nature of ion
sources and mass analyzers, the focus of data processing may differ slightly. For example,
mass ranges lower than 1000 are usually dropped due to the matrix effect when using
MALDI as an ion source;24 signal processing is performed in frequency domain when using
FTMS.32
Typically, data analysis in mass spectrometry contains two parts—signal enhancement
and statistical analysis. The signal enhancement procedure is designed to remove noise,
calibrate the peak intensity and pick the peaks systematically. Based on the processed mass
spectra, statistical or machine learning methods are applied to extract characteristic peaks
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and perform sample classification and biomarker identification. The key steps of statistical
analysis in mass spectrometry are listed and discussed below.
Signal
enhancement

Prepossessing

Smoothing
Baseline
correction

Peak detection

Data mining

Normalization

Feature
selection
Sample
classification
Biomarker
identification

Figure 1.5 Work flow of mass spectra analysis.
1.2.1! Signal enhancement
Separating the signal from noise is the primary step of signal processing. In mass
spectrometry, the signal enhancement consists of preprocessing, which systematically
corrects the signal away from noise; peak detection, which searches for meaningful peaks
within one spectrum; and normalization, which balances the intensity distribution among
spectra.

1.2.1.1! Prepossessing
In order to process the data conveniently, each mass spectrum is converted into a
vector with each dimension defined by a particular m/z value and this value is the peak
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intensity. Then, the first step in mass spectra is to calibrate the information, the peaks, in a
mass spectrum, which usually includes smoothing and baseline correction.

(a)$

(b)$

(c)$

(d)$

Figure 1.6 An example of signal enhancement. (a) Original mass spectrum. (b) Mass
spectrum after smoothing. (c) Mass spectrum after smoothing and baseline correction. (d)
Peak detection.33
Smoothing, like its name, smooths the random noises on the baseline (Figure 1.6 a, b).
Commonly used smoothing filters are moving average filters,34-36 which average the
adjacent points to estimate the baseline and high frequency filters such as Savitsky-Golay
filter,35,36 Gaussian filter,35,37 Kaiser window38 and wavelet transform.39-43 After the mass
spectra have been smoothed, baseline correction (Figure 1.6c) can be performed to balance
the total ion intensity variance due to chemical noises and ions overloading especially in
MALDI,44 GC-MS45 and LC-MS.46
The strategy of baseline correction is to track the baseline profile, which usually comes
from discharging ions during ionization procedure and subtracting the envelope from the
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original signal. Methods commonly used are monotone minimum,40,42 linear
interpolation,39,47-49 Loess,47 wavelet transform41,43 and moving average of minima,50

1.2.1.2! Peak detection
Meaningful peaks can be picked up by either human-based selection or algorithmbased selection (Figure 1.6d). Human-based selection,29,51 which is focused on unique
peaks and mostly relies on the experience, is simple, but needs comprehensive preknowledge that is not suitable for early-stage studies and data with high noise. Thus, it will
be covered in the review. On the other hand, algorithm-based selection, which is focused
on systematically choosing the peaks based on signal-to-noise ratio,34,36,40-42,48-50,52
intensity threshold36,41,47,50 and peak shapes,47 simplifies the selection procedure and
reduces the data volume for further analysis in the mass spectra.
Peak detection and noise reduction can be coupled together. For example, peak
selection criteria based on models35,43,53 are designed by matching peak profiles of interest
and filter out the unmatched peaks on the mass spectra. The model, on the other hand, does
not have to be a well-defined spectrum. Instead, the previous mass spectra of the sample
can be used as the model to perform the matching process. Then, the peak selection is a
correlation process, which is illustrated in Chapter 2.

1.2.1.3! Normalization
Normalization minimizes the peak intensity variance among spectra, which originates
from instrumentation54 and chemical inhomogeneities.55 The most common method is that
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when the original mass spectra are divided by total ion current (TIC), all the spectra will
have the same integrated area among the spectra.55 Newly proposed normalization methods
such as quantile normalization, group-based quantile normalization,56 cyclic loess
normalization,57 and optimal weight factors58 are focused on the correction of peak
distribution.
On the other hand, vector norm (Equation 1.2, Equation 1.3) as a normalization
method has been widely used in library searching59 and metabolomics.60 Vector norm
denotes a mass spectrum as a vector (Equation 1.2) when p equals one (Equation 1.3); this
is equivalent to the commonly used method, which is assigning the most dominant peak as
100 and calculating the relative intensity of the rest peaks. When p equals two, the
normalized mass spectrum is a vector norm or root mean square of the original spectrum.
!"
S = y1 , y2 ,..., yn

!"
S normalized =

Equation 1.2
!"
S

( ∑ yi )
p

1
p

Equation 1.3

i

In addition to scaling the intensity of the peaks in the mass spectra, normalization
methods can also be regarded as weighing procedures, which selectively and
systematically alter the relative intensities of peaks and then weigh more on some unique
peaks. Then, the resulting mass spectra can help to increase the efficiency of data mining
in mass spectra, which is named power normalization and illustrated in detail in Chapter
3 and Chapter 4.
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1.2.2! Data mining in mass spectrometry
With the development of high throughput profiling in samples of lipids, proteins and
various complicated samples in the omics level study, a high volume of data has been
generated within one mass spectrum and one sample.61,62 Data mining is a general
description of many methods that are used to extract useful information or features in mass
spectra. The selected features can be unique peaks m/z, or intensity or peak profiles, which
are usually considered as biomarkers in the research. Commonly used methods are statistics,
machine learning and algorithm design based on the needs.

1.2.2.1! Feature selection and biomarker identification
Feature selection and biomarker identification can be equivalent in mass spectra due
to their function to find unique sets of peaks. For example, the most common types of
biomarkers are unique molecules including protein or peptides to evaluate the severity or
presence of some diseases,63,64 diagnostic ions in proteomics, metabolomics and
carbohydrates study to identify the structure and function,29 and the lipid profile on the
membrane to classify the bacteria types.31 A variety of instruments can be used to analyze
biomarkers

based

on

different

properties,

for

instance

western

blot,65,66

immunohistochemical staining,67,68 enzyme linked immunosorbent assay69 and mass
spectrometry.18,70 In comparison, mass spectrometry can provide high sensitivity and
resolution analysis for different target ions in complicated samples at molecular levels
because it has been widely used in the research of disease studies, proteomics,
metabolomics and other popular topics.
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(a)$

(b)$

(d)$

(e)$

(c)$

(f)$

Figure 1.7 An example of statistics analysis of biomarker identification of potential
peptide signatures in serum samples from breast cancer mice. The vertical scattering plot
of peak (a) m/z 904.48, (b) m/z 1227.6, (c) m/z 1374.75, (d) m/z 1475.80, (e) m/z
1576.84 and (f) m/z 1821.95. * P<0.05, **P<0.01 and ***P<0.001.63
In statistics, t-test and ANOVA associated with p-value comparison

63,71

is used for

feature selection for a given set of peaks. An example of t-test analysis of biomarker is in
Figure 1.7, in which six potential peptides are selected and the t-test is performed to identify
the relation within the groups at different developmental stages (i.e., 0, second, fourth, sixth
and eighth weeks). The result in the figure reveals some statistical significance between
different groups. In order to control Type 1 error, a modified p-value comparison has been
proposed.72 In this method, data are resampled many times to get multiple p values and
calculated to obtain one resampled p-value, which is usually smaller than the original value.
The statistical method is frequently used to validate potential biomarkers; however it is not
suitable for using solely in the early stage exploration when the quality of spectra is not
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adjusted to the optimum conditions and the candidates of biomarkers are not fully
understood.
On the other hand, machine learning methods classify samples first and then use the
best classification result to weigh the most important features contributing to the result.
These methods include supervised learning, such as decision trees, neural networks and
supporting vector machine; unsupervised learning such as clustering; and reinforcement
learning such as Markov decision process and game theory and various combination
methods. Compared to the statistics method, machine learning methods that find
biomarkers are easy to interpret and visualize without extensive pre-knowledge in selecting
potential biomarkers; thus, these are more efficient to use in large volumes of data and in
early stage experiments.

1.2.2.2! Sample classification using machine learning methods
Unsupervised methods in data mining classify samples without prior knowledge. On
the other hand, supervised methods need some samples with known identities, such as the
training group, to generate the classification boundary. Both methods are used frequently
in sample classification in mass spectrometry. Because of the training group, supervised
methods usually have higher classification accuracy and it is more suitable for data with
high noise and large volume,73 which is typical for early stage experiments. Sometimes,
unsupervised methods are used first as the feature selection tool, and the selected features
are used as the input to the supervised methods to achieve higher classification accuracy.74
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1.2.2.2.1! Unsupervised data mining
Cluster analysis is one of the widely used unsupervised methods. When using cluster
analysis, each sample point is projected into a new direction, which maximizes the distance
among the data points and highlights the differences of each sample. Then, in order to
visualize the similarity and difference, a projection plot can be generated with two or three
principal projection directions with the highest distance. The similar sample points are
gathered in a project plot as a cluster (Figure 1.8).

Figure 1.8 PCA score plot of 11 types of bacteria.31
The most commonly used cluster analysis is principal component analysis (PCA),
which uses linear orthogonal transformation of the sample points to maximize the
difference.75 The figure below is the two-dimension PCA score plot of classification of 11
types of bacteria;the same kind of bacteria is located relatively in a nearby cluster. Also,
PCA can be plotted in three-dimensional figures by accounting in three principal
component analysis.
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Other clustering techniques have also been used commonly in the biomarker
identification and sample classification, such as hierarchical clustering and k-means
clustering. Figure 1.9 is a dendrogram of a typical result of the hierarchical clustering. The
height in the vertical direction represents the distance (difference) among each cluster, and
along horizontal axes is the list of all the samples. It usually uses Euclidean distance as the
metric to determine the linkage of the samples at different linkage stages.76 This is
advantageous because it uses all the information in a mass spectrum to present the linkage
information instead of the several principal components; also it shows the cluster
information at different stages with different precision.76 However, it is quite timeconsuming for large data sets with at least n2logn (n is the number of data points in one
mass spectrum) times of calculation.77

Figure 1.9 An example of hierarchical clustering. HER2 is human epidermal growth
factor receptor 2, which is a criterion to therapeutic decision making in breast cancer
patients. In this study, MALDI is used to classify breast cancer tissue, which is preclassified based on HER2 using fluorescence and immunohistochemical analysis.76
K-means clustering is another type of cluster analysis. In contrast to the previous
analysis, it pre-sets a fixed number of clusters, k, and partitions all the samples to k clusters
so as to minimize the inter-cluster distance. Because the total number (k) of sample types
is known, the result has been improved compared to previous methods.73
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Also, the selected principal scores in cluster analysis can be post-processed to
calculate one value, which is plotted by pseudo-color code (Figure 1.10). Thus, in the figure,
each pixel is a combination of the cluster score calculated. This technique is called spatial
segmentation and is used widely in mass spectrometry imaging.

(a)$

(b)$

(c)$

Figure 1.10 (a) Optical image (b) Straightforward k-means clustering of spectra. (c)
Hierarchical clustering followed by PCA reduction of the original spectra.78

1.2.2.2.2! Supervised data mining
In supervised classification for mass spectrometry, samples are usually randomly
separated as training group and testing group, where the training group is used to
generate or modify classification criteria and the testing group is used to evaluate the
performance of the classifier. The commonly used supervised methods in mass
spectrometry are linear discriminant analysis, k-nearest neighbor, random forest, neural
networks and supporting vector machine.
Linear discriminant analysis (LDA) was first proposed by Fisher79 in 1936. Based on
the assumptions that all the groups have a normal distribution of the data points, it finds a
linear combination of all the m/zs that maximize the inter-group difference and minimize
the intra-group variance. Due to its simplicity, it has been used in the study of proteomics,80
cell wall profile81 and metabolomics.82 On the other hand, k-nearest neighbor (kNN) is
another simple supervised method, which was used frequently in the mass spectra studies
of cancer diagnosis.83-85 It selected k-nearest sample points around an unknown sample,
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and the identity of the unknown is determined by the percentage of each group within the
k samples. An illustration of using kNN where k is 10 to determine the identity of unknown
“X” among three kinds of groups (type1, type2 and type3) is shown in Figure 1.11a. When
using Euclidean distance (using circles to embrace samples), ten nearest samples are
selected and the identity of unknown is type 2 via counting the samples. Due to simple
assumption and model of the classification, both LDA and kNN need to do a peak reduction
procedure before actually achieving an acceptable classification result,85,86 which
sometimes may introduce bias and unstable error rate.73

(b)$
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8
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Figure 1.11 (a)An example of kNN where k is 10. “X” is the location of unknown sample
and the black circle is the calculated neighbors of “X” using Euclidean distance. (b)A
scheme of random forest for sample classification in mass spectrometry.
A different classification method is random forest, which consists of many decision
trees. Just as its name indicates, a decision tree has many nodes and branches, where each
branch is a classification criteria and each node is a result (Figure 1.11b). Because the
criteria for each decision tree is very limited, the random forest gathers the result of
multiple trees and uses panels to vote for a final result. This method is relatively
complicated because many classification criteria are used; when input peaks are larger than
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the number of training samples, the amount of calculation is huge, although it is stable
regarding error rates.73
Even though artificial neural networks (ANN) can be used in a supervised and
unsupervised way, the supervised method with training groups is more favored by
researchers in mass spectrometry due to higher classification accuracy.73,87,88 The simplest
ANN has three layers: the input layer, which is the sample data, the output layer, which is
the category of the data, and the hidden layer, which is the fitting relation between the input
and output (Figure 1.12a). When using an ANN, sample data are automatically divided into
training, validating and testing. The advantage of ANN is the learning procedure, which by
each time of the validating, the coefficient in the fitting will be adjusted to improve the
classification efficiency.89 The disadvantage is that multiple trials and experiences are
needed to set up the number of layers, which is usually set to 1 in most studies and the
learning procedure is relatively time-consuming for large data sets.73,90
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Figure 1.12 (a)A type design of ANN with two inputs, one hidden layer and one output.
(b) Illustration of using supporting vector machine to classify mass spectra. The vector is
mapped into a high dimension space, where a classification boundary is generated using
the maximum margin by training data.
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Compared to other methods, the supporting vector machine has the most tolerance
for low quantities of samples and high volumes of data within one sample spectrum.73,91
SVM projects the training data into a high dimension space in which a maximum-margin
hyper-plane can be found to classify two groups. It then projects the testing data on the
same space to predict the category (group) of the sample based on the position relative to
the hyper-plane (Figure 1.12b). For classifying more than two types of samples, a “oneagainst-one” multi-class SVM is required to differentiate each two classes.92
Every algorithm has its disadvantages and advantages. Many of the studies found
that the classification result has no statistically significant difference when using different
methods.73,90. However, the other studies found one has a better performance.73,90 Thus, the
result is highly dependent on the nature of the data and the algorithm mechanisms. Most
of time, because simply applying one method cannot achieve optimum performance,
algorithms are designed depending on the data nature; these can be seen in Chapter 3 and
Chapter 4.

1.3! Conclusion
Mass spectrometry has been widely used in the analysis of trace-level molecules in
complicated samples such as blood, urine and food. Due to high sensitivity and high
variation in the mass spectra, especially in early stage experiments, picking up meaningful
information and filtering out the matrix effect and background noise have paramount
importance.
A typical data processing procedure in mass spectrometry includes the two steps: the
first is the prepossessing, which is designed to filter out the noise and calibrate and enhance
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the peaks on a general level; the second step is data mining, which is used to extract the
important information such as characteristic peaks, peak relations and profiles, which can
be further identified as biomarkers. Any advanced algorithms cannot guarantee an
optimum classification because they are highly dependent on the data property, including
the matrix effect, intensity and variation.
This thesis features a data prepossessing algorithm, self-correlation, in Chapter 2,
which is ideal for Fourier transform mass spectrometry while collecting signals in the
frequency domain. Based on the practical uses, including the convenience of data
collecting and usage of internal standards, three scenarios consisting of broadband MS
analysis, selected ion monitoring and intra-SC using a single data set have also been
proposed.
Chapters 3 and 4 are focused on algorithm development especially for the early stage
experiment, which has a high matrix effect and low sample quantity. Regarding the high
matrix effect and intensity variation, power normalization is proposed to automatically
assign optimum weighing factors to the peaks on the mass spectra.

In addition,

classification errors have been considered to increase the classification accuracy by
calculating the probability. Also, different classification methods have been compared to
the final choice of SVM due to its capability to handle low sample quantity. Though the
methods proposed are based on the application of mass spectra, they are capable of solving
any classification-related problems in practice.

20
1.4! References
(1) Chan, K. Chemosphere 2003, 52, 1361-1371.
(2) Klee, G. G. Clinical Chemistry 2000, 46, 1277-1283.
(3) Tudos, A. J.; Besselink, G. A. J.; Schasfoort, R. B. M. Lab on a Chip 2001, 1, 83-95.
(4) Bondarenko, P. V.; Second, T. P.; Zabrouskov, V.; Makarov, A. A.; Zhang, Z.
Journal of the American Society for Mass Spectrometry 2009, 20, 1415-1424.
(5) Parikh, H. H.; McElwain, K.; Balasubramanian, V.; Leung, W.; Wong, D.; Morris, M.
E.; Ramanathan, M. Pharmaceutical Research 2000, 17, 632-637.
(6) Rehder, D. S.; Dillon, T. M.; Pipes, G. D.; Bondarenko, P. V. Journal of
Chromatography A 2006, 1102, 164-175.
(7) Campana, S. E. Marine Ecology Progress Series 1999, 188, 263-297.
(8) Rogge, W. F.; Hildemann, L. M.; Mazurek, M. A.; Cass, G. R.; Simoneit, B. R. T.
Environmental Science & Technology 1993, 27, 636-651.
(9) Naczk, M.; Shahidi, F. Journal of Chromatography A 2004, 1054, 95-111.
(10) Lehotay, S. J.; de Kok, A.; Hiemstra, M.; van Bodegraven, P. Journal of Aoac
International 2005, 88, 595-614.
(11) Robbins, R. J. Journal of Agricultural and Food Chemistry 2003, 51, 2866-2887.
(12) Takats, Z.; Wiseman, J. M.; Cooks, R. G. Journal of Mass Spectrometry 2005, 40,
1261-1275.
(13) Covey, T. R.; Lee, E. D.; Henion, J. D. Analytical Chemistry 1986, 58, 2453-2460.
(14) Nagaraj, N.; Wisniewski, J. R.; Geiger, T.; Cox, J.; Kircher, M.; Kelso, J.; Paeaebo,
S.; Mann, M. Molecular Systems Biology 2011, 7.
(15) Yates, J. R.; Ruse, C. I.; Nakorchevsky, A. In Annual Review of Biomedical
Engineering, 2009, pp 49-79.
(16) Bader, G. D.; Hogue, C. W. Bmc Bioinformatics 2003, 4.
(17) Craig, R.; Beavis, R. C. Bioinformatics 2004, 20, 1466-1467.
(18) Smith, C. A.; Want, E. J.; O'Maille, G.; Abagyan, R.; Siuzdak, G. Analytical
Chemistry 2006, 78, 779-787.
(19) Bleakney, W. Physical Review 1929, 34, 157-160.
(20) Nier, A. O. Rev.Sci. Instrum., 1947, 415.
(21) Mann, M.; Meng, C. K.; Fenn, J. B. Analytical Chemistry 1989, 61, 1702-1708.
(22) Fenn, J. B.; Mann, M.; Meng, C. K.; Wong, S. F.; Whitehouse, C. M. Science 1989,
246, 64-71.
(23) Harper, J. D.; Charipar, N. A.; Mulligan, C. C.; Zhang, X.; Cooks, R. G.; Ouyang, Z.
Analytical Chemistry 2008, 80, 9097-9104.
(24) Karas, M.; Bachmann, D.; Bahr, U.; Hillenkamp, F. International Journal of Mass
Spectrometry and Ion Processes 1987, 78, 53-68.
(25) Liu, J.; Wang, H.; Manicke, N. E.; Lin, J.-M.; Cooks, R. G.; Ouyang, Z. Analytical
Chemistry 2010, 82, 2463-2471.
(26) Wang, H.; Liu, J.; Cooks, R. G.; Ouyang, Z. Angewandte Chemie-International
Edition 2010, 49, 877-880.
(27) Hoffmann, E., Stroobant., V. Mass Spectrometry: Principles and Applications, 3 rd
ed.; Wiley, 2007.

21
(28) Su, Y.; Wang, H.; Liu, J.; Wei, P.; Cooks, R. G.; Ouyang, Z. Analyst 2013, 138,
4443-4447.
(29) Konda, C.; Londry, F. A.; Bendiak, B.; Xia, Y. Journal of the American Society for
Mass Spectrometry 2014, 25, 1441-1450.
(30) Manicke, N. E.; Abu-Rabie, P.; Spooner, N.; Ouyang, Z.; Cooks, R. G. Journal of
the American Society for Mass Spectrometry 2011, 22, 1501-1507.
(31) Zhang, J. I.; Costa, A. B.; Tao, W. A.; Cooks, R. G. Analyst 2011, 136, 3091-3097.
(32) Marshall, A. G.; Hendrickson, C. L.; Jackson, G. S. Mass spectrometry reviews
1998, 17, 1-35.
(33) Yang, C.; He, Z.; Yu, W. BMC Bioinformatics 2009, 10, 4.
(34) Li X, G. R., Lu X, Shi Q, Iglehart JD, Harris L, Miron A. Bioinformatics and
Computational Biology Solutions Using R and Bioconductor 2005.
(35) Leptos, K. C.; Sarracino, D. A.; Jaffe, J. D.; Krastins, B.; Church, G. M. Proteomics
2006, 6, 1770-1782.
(36) Katajamaa, M.; Miettinen, J.; Oresic, M. Bioinformatics 2006, 22, 634-636.
(37) Yasui, Y.; Pepe, M.; Thompson, M. L.; Adam, B. L.; Wright, G. L.; Qu, Y. S.;
Potter, J. D.; Winget, M.; Thornquist, M.; Feng, Z. D. Biostatistics 2003, 4, 449-463.
(38) Mantini, D.; Petrucci, F.; Pieragostino, D.; Del Boccio, P.; Di Nicola, M.; Di Ilio, C.;
Federici, G.; Sacchetta, P.; Comani, S.; Urbani, A. Bmc Bioinformatics 2007, 8.
(39) Bellew, M.; Coram, M.; Fitzgibbon, M.; Igra, M.; Randolph, T.; Wang, P.; May, D.;
Eng, J.; Fang, R.; Lin, C.; Chen, J.; Goodlett, D.; Whiteaker, J.; Paulovich, A.; McIntosh,
M. Bioinformatics 2006, 22, 1902 - 1909.
(40) Coombes, K.; Tsavachidis, S.; Morris, J.; Baggerly, K.; Hung, M.; Kuerer, H.
Proteomics 2005, 5, 4107 - 4117.
(41) Du, P.; Kibbe, W.; Lin, S. Bioinformatics 2006, 22, 2059 - 2065.
(42) Karpievitch, Y.; Hill, E.; Smolka, A.; Morris, J.; Coombes, K.; Baggerly, K.;
Almeida, J. Bioinformatics 2007, 23, 264 - 265.
(43) Lange, E.; Gropl, C.; Reinert, K.; Kohlbacher, O.; Hildebrandt, A. Pac Symp
Biocomput 2006, 243 - 254.
(44) Krutchinsky, A. N.; Chait, B. T. Journal of the American Society for Mass
Spectrometry 2002, 13, 129-134.
(45) Gross, J. H. Mass Spectroemtry: A Textbook; Springer: Heidelberg, Germany, 2004.
(46) Wang, W.; Zhou, H.; Lin, H.; Roy, S.; Shaler, T. A.; Hill, L. R.; Norton, S.; Kumar,
P.; Anderle, M.; Becker, C. H. Analytical Chemistry 2003, 75, 4818-4826.
(47) Li, X.; Gentleman, R.; Lu, X.; Shi, Q.; Iglehart, J.; Harris, L.; Miron, A.
Bioinformatics and Computational Biology Solutions Using R and Bioconductor 2005, 91
- 109.
(48) Mantini, D.; Petrucci, F.; Pieragostino, D.; DelBoccio, P.; Nicola, M.; Ilio, C.;
Federici, G.; Sacchetta, P.; Comani, S.; Urbani, A. BMC Bioinformatics 2007, 8, 101.
(49) Yasui, Y.; Pepe, M.; Thompson, M.; Adam, B.; Wright, G.; Qu, Y.; Potter, J.;
Winget, M.; Thornquist, M.; Feng, Z. Biostatistics 2003, 4, 449 - 463.
(50) Du, P.; Sudha, R.; Prystowsky, M.; Angeletti, R. Bioinformatics 2007, 23, 1394 1400.
(51) Fang, T. T.; Bendiak, B. Journal of the American Chemical Society 2007, 129, 97219736.

22
(52) Smith, C.; Want, E.; Maille, G.; Abagyan, R.; Siuzdak, G. Analytical Chemistry
2006, 78, 779 - 787.
(53) Du, Y. M.; Xu, W.; Ouyang, Z. International Journal of Mass Spectrometry 2012,
325, 73-79.
(54) Norris, J. L.; Cornett, D. S.; Mobley, J. A.; Andersson, M.; Seeley, E. H.; Chaurand,
P.; Caprioli, R. M. International Journal of Mass Spectrometry 2007, 260, 212-221.
(55) Deininger, S.-O.; Cornett, D. S.; Paape, R.; Becker, M.; Pineau, C.; Rauser, S.;
Walch, A.; Wolski, E. Analytical and Bioanalytical Chemistry 2011, 401, 167-181.
(56) Wei, X.; Sun, W.; Shi, X.; Koo, I.; Wang, B.; Zhang, J.; Yin, X.; Tang, Y.;
Bogdanov, B.; Kim, S.; Zhou, Z.; McClain, C.; Zhang, X. Anal. Chem. 2011, 83, 76687675.
(57) Dudoit, S.; Yang, Y. H.; Callow, M. J.; Speed, T. P. Statistica Sinica 2002, 12, 111139.
(58) Kim, S.; Koo, I.; Wei, X.; Zhang, X. Bioinformatics 2012, 28, 1158-1163.
(59) Crawford, L. R.; Morrison, J. D. Analytical Chemistry 1968, 40, 1464-&.
(60) Sysi-Aho, M.; Katajamaa, M.; Yetukuri, L.; Oresic, M. Bmc Bioinformatics 2007, 8.
(61) Burkard, T. R.; Planyavsky, M.; Kaupe, I.; Breitwieser, F. P.; Buerckstuemmer, T.;
Bennett, K. L.; Superti-Furga, G.; Colinge, J. Bmc Systems Biology 2011, 5.
(62) Ghaemmaghami, S.; Huh, W.; Bower, K.; Howson, R. W.; Belle, A.; Dephoure, N.;
O'Shea, E. K.; Weissman, J. S. Nature 2003, 425, 737-741.
(63) Li, Y. J.; Li, Y. G.; Chen, T.; Kuklina, A. S.; Bernard, P.; Esteva, F. J.; Shen, H. F.;
Ferrari, M.; Hu, Y. Clinical Chemistry 2014, 60, 233-242.
(64) Eberlin, L. S.; Norton, I.; Dill, A. L.; Golby, A. J.; Ligon, K. L.; Santagata, S.;
Cooks, R. G.; Agar, N. Y. R. Cancer Research 2012, 72, 645-654.
(65) Gronborg, M.; Kristiansen, T. Z.; Iwahori, A.; Chang, R.; Reddy, R.; Sato, N.;
Molina, H.; Jensen, O. N.; Hruban, R. H.; Goggins, M. G.; Maitra, A.; Pandey, A.
Molecular & Cellular Proteomics 2006, 5, 157-171.
(66) Mishra, J.; Dent, C.; Tarabishi, R.; Mitsnefes, M. M.; Ma, Q.; Kelly, C.; Ruff, S. M.;
Zahedi, K.; Shao, M.; Bean, J.; Mori, K.; Borasch, J.; Devarajan, P. Lancet 2005, 365,
1231-1238.
(67) Rubin, M. A.; Zhou, M.; Dhanasekaran, S. M.; Varambally, S.; Barrette, T. R.;
Sanda, M. G.; Pienta, K. J.; Ghosh, D.; Chinnaiyan, A. M. Jama-Journal of the American
Medical Association 2002, 287, 1662-1670.
(68) Schleicher, E. D.; Wagner, E.; Nerlich, A. G. Journal of Clinical Investigation 1997,
99, 457-468.
(69) Schenk, D.; Barbour, R.; Dunn, W.; Gordon, G.; Grajeda, H.; Guido, T.; Hu, K.;
Huang, J. P.; Johnson-Wood, K.; Khan, K.; Kholodenko, D.; Lee, M.; Liao, Z. M.;
Lieberburg, I.; Motter, R.; Mutter, L.; Soriano, F.; Shopp, G.; Vasquez, N.; Vandevert,
C.; Walker, S.; Wogulis, M.; Yednock, T.; Games, D.; Seubert, P. Nature 1999, 400,
173-177.
(70) Pisitkun, T.; Shen, R. F.; Knepper, M. A. Proceedings of the National Academy of
Sciences of the United States of America 2004, 101, 13368-13373.
(71) Pereira, J.; Porto-Figueira, P.; Cavaco, C.; Taunk, K.; Rapole, S.; Dhakne, R.;
Nagarajaram, H.; Camara, J. S. Metabolites 2015, 5, 3-55.

23
(72) P. Westfall, S. S. Y. Resampling-Based Multiple Testing, Examples and Methods
For pp-Value Adjustment; John Wiley & Sons, New York, 1993.
(73) Datta, S.; DePadilla, L. M. Statistical Methodology 2006, 3, 79-92.
(74) Balog, J.; Szaniszlo, T.; Schaefer, K.-C.; Denes, J.; Lopata, A.; Godorhazy, L.;
Szalay, D.; Balogh, L.; Sasi-Szabo, L.; Toth, M.; Takats, Z. Analytical Chemistry 2010,
82, 7343-7350.
(75) Pearson, K. Philosophical Magazine Series 6 1901, 2, 559-572.
(76) Rauser, S.; Marquardt, C.; Balluff, B.; Deininger, S.-O.; Albers, C.; Belau, E.;
Hartmer, R.; Suckau, D.; Specht, K.; Ebert, M. P.; Schmitt, M.; Aubele, M.; Höfler, H.;
Walch, A. Journal of Proteome Research 2010, 9, 1854-1863.
(77) Sibson, R. The Computer Journal 1973, 16, 30-34.
(78) Alexandrov, T. BMC Bioinformatics 2012, 13, S11.
(79) Fisher, R. A. Annals of Eugenics 1936, 7, 179-188.
(80) Park, S. K.; Venable, J. D.; Xu, T.; Yates, J. R. Nature Methods 2008, 5, 319-322.
(81) Chen, L. M.; Carpita, N. C.; Reiter, W. D.; Wilson, R. H.; Jeffries, C.; McCann, M.
C. Plant Journal 1998, 16, 385-392.
(82) Kim, K.; Aronov, P.; Zakharkin, S. O.; Anderson, D.; Perroud, B.; Thompson, I. M.;
Weiss, R. H. Molecular & Cellular Proteomics 2009, 8, 558-570.
(83) Wu, B. L.; Abbott, T.; Fishman, D.; McMurray, W.; Mor, G.; Stone, K.; Ward, D.;
Williams, K.; Zhao, H. Y. Bioinformatics 2003, 19, 1636-1643.
(84) Ozcift, A.; Gulten, A. European Journal of Mass Spectrometry 2008, 14, 267-273.
(85) Li, L. P.; Umbach, D. M.; Terry, P.; Taylor, J. A. Bioinformatics 2004, 20, 16381640.
(86) Hong, Y.-j.; Wang, X.-d.; Shen, D.; Zeng, S. Acta Pharmacologica Sinica 2008, 29,
1240-1246.
(87) Wulfkuhle, J. D.; Liotta, L. A.; Petricoin, E. F. Nature Reviews Cancer 2003, 3, 267275.
(88) Blom, N.; Sicheritz-Ponten, T.; Gupta, R.; Gammeltoft, S.; Brunak, S. Proteomics
2004, 4, 1633-1649.
(89) Basheer, I. A.; Hajmeer, M. Journal of Microbiological Methods 2000, 43, 3-31.
(90) Tu, J. V. Journal of Clinical Epidemiology 1996, 49, 1225-1231.
(91) Burges, C. J. C. Data Mining and Knowledge Discovery 1998, 2, 121-167.
(92) Platt, J. C.; Cristianini, N.; Shawe-Taylor, J. In Advances in Neural Information
Processing Systems 12, Solla, S. A.; Leen, T. K.; Muller, K. R., Eds., 2000, pp 547-553.

24

CHAPTER 2.! SELF-CORRELATION METHOD FOR PROCESSING RANDOM
PHASE SIGNALS IN FOURIER TRANSFORM MASS SPECTROMETRY

2.1! Introduction.
Mass spectrometry (MS) provides high specificity and sensitivity for chemical
analysis and the mass analysis can be performed through a variety of methods. Fourier
transform mass spectrometry (FTMS) has been traditionally implemented with ion
cyclotron resonance (ICR)1,2 and later with Orbitrap mass spectrometers,3 which provide
high resolution and high mass accuracy. The motion frequencies of the trapped ions are
detected through the image current measurement1,4-6 followed by the Fast Fourier
Transform (FFT).1,3,7-10 As an alternative and non-destructive mass analysis method,
Fourier transform mass analysis has also been explored for ion trap mass
spectrometers.4,5,11 Recently it has been performed at high pressures (up to 50 mTorr) using
a constant excitation while measuring a non-decaying harmonic motion of the ions.12
In FTMS, dedicated electronics are typically developed and used to control the phases
in ion excitation and signal recording13-15 because random phases result in a decrease in the
efficiency for signal enhancement using common data processing methods such as
averaging. The signal-to-noise ratio (SNR) can typically be significantly improved through
the averaging of data sets with the signals in the same phase; however, averaging of two
data sets with different initial phases (with the reference to the ion excitation) of the
recorded signals might not improve the SNR (Figure 2.1).
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(a)

(b)

(c)

(d)

(e)

(f)

Figure 2.1 Averaging of data sets without signal phase control. Data sets (a) and (b)
(green) with signals (black) of different initial phases and white Gaussian noise (WGN).
(c) The averaged data set. The corresponding spectra after FFT shown in (d) and (f).

In addition to the phase control during the data recording, different algorithms have
been explored to extract the phase information of the signals in data sets, which can be
used in the subsequent steps in the data processing.16-23 Improvements in the resolution and
SNR in Fourier transform MS can be achieved using methods such as absorption mode,1624

data reflection,25, and Hartley/Hilbert transform,26 etc., with the phases identified for

signals in the data sets. However, finding the signal phases accurately can be difficult and
the methods for doing so are typically mathematically complicated. Other methods have
also been developed for processing data of different phases without requiring the extraction
of the phase information, such as magnitude-mode derivation,27,28 autoregression model,29
maximum entropy method,30 regressing analysis of Lorentzian distribution,25 and wavelet
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transform.31 These methods perform a direct process of the data, but sometimes can require
long computation time and can have artifacts induced in the processed signals.25
When FTMS was applied using ion trap, the image current measurement suffers from
the interference by the trapping RF signal4,5,11 as well as the fast decay of the coherent ion
trajectories.5,7,32 In comparison with other mass analyzers, ion trap has an advantage of
trapping and mass analyzing ions at relatively high pressures (>1 mTorr);33,34 however, the
amplitudes of the ion motions decrease significantly in a short period of time (< 1ms )1 due
to the collisional cooling with the background gas molecules. Using a constant excitation
to sustain the coherent ion trajectories while measuring the harmonic motions, FTMS have
been successfully performed at 1-50 mTorr. A narrow band filter has been used to minimize
the interferences due to the trapping RF and the excitation AC signals.12 It is highly
desirable to implement a broadband FTMS with ion trap for a simultaneous detection of
ions over a wide m/z range, while this remains an interesting challenge with the
requirement of a significant enhancement of the SNR and with a difficulty in the
availability of the high quality wide-band filters.
In this study, we explored a method for processing data of random phases using a
simple algorithm based on the self-correlate (SC) function. Correlation function was first
developed by Norbert Wiener in 194935 and has been previously introduced for information
analysis with mass spectrometry data,36 such as the identification of isotope distribution37,38
or search of ion fragments in standard libraries.39 Here we investigate the possibility of
applying SC method for improving the SNR in the FTMS spectra using data acquired at
random initial phases by image current measurements. Though the data used in the
characterization of the SC method in this study are simulated based on the experimental
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data previously collected for FTMS using an ion trap,12 the demonstrated capability of the
SC methods should also be applicable to data recorded using ICR or Orbitrap.

2.2! Algorithm
2.2.1! Self-correlation in the FTMS with random phase
Assuming S(m1) and S(m2) are the two sets of data recorded at different phases through
image current measurements and each contains m1 and m2 data points, the mathematical
model of SC function is defined as

SC(m1 ,m2 )= E{S * (m1 )S(m2 )}

Equation 2.1

where E is the expectation. The data recorded is a combination of the signal V at a random
phase Φ and a white Gaussian noise (u), which the expectation of u(m), E(u(m)) is zero.
Then, Equation (1) can be converted to
SC(m1 , m2 ) = E{[V (m1 ,Φ) + u(m1 )]* × [V (m2 ,Φ) + u(m2 )]}

Equation 2.2

where Φ is the function of a homogeneous distribution between (0, 2π). Assuming that the
noises and signals are independent, Equation 2.2 canbe expanded as

SC(m1 ,m2 ) = E[V (m1 ,Φ)V (m2 ,Φ)] + E[V (m1 ,Φ)]E[u(m2 )] + E[V (m2 ,Φ)]E[u(m1 )]
+ E[u(m1 )]E[u(m2 )] = E[V (m1 ,Φ)V (m2 ,Φ)]
Equation 2.3
The phase Φ is random with a homogeneous distribution between (0, 2π) and the
probability density p(φ)of Φ is calculated as

1
p(ϕ ) =
!!!!!0 ≤ ϕ ≤ 2π
Equation 2.4
2π
!
In a simple case with data recorded for ions of a single m/z value, which contains a signal
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at one frequency f, V(m, Φ) can be written as
V (m,Φ) = Asin(2π fmT + Φ)

Equation 2.5

The expectation µv(m) of V(m, Φ) can be calculated as

µV (m) = E{Asin(2π fmTs + Φ)}
=∫

2π

0

Asin(2π fmTs + ϕ )

1
dϕ = 0
2π

Equation 2.6

Then, the Equation 2.3 can then be written as

SC(m1 ,m2 ) = E{A2 sin(2π fm1Ts + Φ + ϕ 0 )sin(2π fm2Ts + Φ)}
A2 2π
sin(2π fm1Ts + ϕ + ϕ 0 )sin(2π fm2Ts + ϕ )dϕ
2π ∫0
A2
=
cos[2π f (m2 − m1 )Ts + ϕ 0 ]
2
=

Equation 2.7

where φ0 is the initial phase of S(m1).
Similarly, for data containing signals at more than one frequency, the SC function can
be written as

SC(m1 ,m2 ) = E{[ A1 sin(2π f1m1Ts + Φ + ϕ 0 ) +!+ An sin(2π f n m1Ts + Φ + ϕ 0 )]
⋅[ A1 sin(2π f1m2Ts + Φ) +!+ An sin(2π f 2 m2Ts + Φ)]}
Equation 2.8
After the two data sets are processed with the SC method, a new data set with (m1+
m2 - 1 ) data points are generated. The SC value can be expressed as:

SC(k) =

1 n 2
∑ A cos[2π fi kTs + ϕ0 ]
2 i=1 i

Equation 2.9

where Ai (with i =1 to n) is the amplitude of the ion motion at frequency fn , k = (0, 1, …
(m1+ m2 )), Ts is the sampling interval, and φ0 is the initial phase of S(m1).
Based on Equation 2.9, several conclusions can be drawn for the SC method: a) the
noise (u) is highly reduced; b) the SNR is increased with a square factor after each time SC

29
is applied (Ai to Ai2/2); c) difference in phase of the data is eliminated, with the phase of the
processed data being the same as that of the original data set S(m1).
The Equation 2.9 is derived based on the assumption of the independence among the
noises and the independence between the noises and the signals. However, the correlation
coefficients might not always be 0 in a real case, which could result in a relatively high
background noise in the processed spectra after SC. Thus, in a real case the noises might
not be independent, so the Equation 2.9 is revised as
SC(k) =

1 n
∑ ( A + rσ )2 cos[2π fi kTs + ϕ0 ] + r0σ 2
2 i=1 i i

Equation 2.10

where ri and r0 are constants indicating the correlation coefficient between the signal and
noise and among the noises, respectively. They are dependent on the randomness of the
noise. If the data sets are of a same length, a fast SC can be performed,36 which highly
reduces the calculation time. It is done by first getting the FFT of both data sets as defined
below:
F[SC(m1 , m2 )] = F[S(m1 )]⋅ F[S(m2 )]*

Equation 2.11

As a simple demonstration of the SC method, two data sets, Data I (Figure 2.2a) and
Data II (Figure 2.2b), are generated with ion motions at two different frequencies at 110
and 120 kHz. Gaussian white noises (WGN) have been generated to simulate the signals
recorded using image current measurement in a previous study.12 These two data sets have
initial phases with a difference of π/2. Applying SC for one time (noted as SC1) with Data
I and Data II, the result obtained is shown Figure 2.2c, with the SNR significantly
improved for the peaks in the spectrum in frequency domain. After SC1, the amplitude is
changed to one half of the squared amplitude and can by further improved by applying SC
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multiple times (noted as SCn) with additional data sets, which will be further discussed
later in this manuscript.
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Figure 2.2 Data I (a) and Data II (b) contains signals at 110 kHz and 120 kHz with a
difference of π/2 in initial phases and random Gaussian white noise. (c) The data set and
spectrum obtained after processing with SC method.

2.2.2! Calibration of relative intensity
While the SNR is improved, the ratio of the relative intensities of the two peaks is also
changed by a square factor. The relative abundances of ions in mass spectra are important
since they represent the relative concentrations of the analytes in the original mixture. It is
also an important practice to add internal standards (IS) into the samples and to use the
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relative analyte-to-IS ratios for quantitation. The change in the peak ratio after the SC can
be corrected by getting the square root of the processed intensity of each peak.
Assuming analytes A has the dominant peak which is normalized to a intensity of
100 in the mass spectra, if the intensity of a lower peak B is noted as B0 before SC, and
B1, B2, …and Bn after SC1, SC2…,and SCn, respectively,
then,

B1 =

B0 2
100

B0
B03
B2 = B1
=
100 1002
…

Bn =

B0 n+1
100 n

Thus, B0 is calculated as
B0 = n+1 Bn ⋅100 n

Equation 2.12

Thus, Equation S12 is transition function is derived to express the relationship
between the intensities of the peak for B before (B0) and after (Bi) applying SC i times
2.2.3! Calibration of signal-to noise ratio
In a spectrum with high background noise, both B0 and Bn are summations of the noise
and the signal. Assuming the noise level IN after the SCn is
I N = σ n + µn

Equation 2.13

where σn and µn are the standard deviation and the average of the noise, respectively.
Then intensity ratio (highest peak/B) measured from the spectrum is

Ratiomeasured =
The estimated ratio is then given by

100 100 + I N
=
B0
B + IN

Equation 2.14
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Re =

A
100
104
=
=
B (100 + I N )B0
(100 + I N )Bo − 100I N
− IN0
100

Equation 2.15

which represents the intensity ratio between the two compounds (A/B) in the mixture. The
accuracy of the peak ratio can be calculated with

Pr % =

| Re − Rreal |
100%
Rreal

Equation 2.16

In this study, the data were simulated with SNRs defined as

SNR = 20log10

norm(V )
norm(U )

Equation 2.17

where V is the signal related to ion motions and U is the noise, and norm means the
normal number of the whole data sets (V or U), which indicates the energy of the signal
or noise. For the peaks in the spectra based on the data processed wtih SC method, the
observed signal-to-noise ratio is defined as

!" #" $ =

&"
!
&#

Equation 2.18

where the IP is the intensity of the peak and IN is the noise level, which both are measured
directly from the spectra.
2.3! Data simulation
The generation of the simulated data sets and the processing of them with SC method
were implemented using home written programs in MatLab (version R2010a, MathWorks,
Natick, MA, USA,). The original data sets were simulated based on the experimental data
previously recorded for image current measurement using a linear ion trap at pressure as
high as 50mTorr.12 The peak width was about 5 kHz with some broadening due to the ion
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motion at relatively low q (low potential well depth) and a space charge effect.
To generate the simulated data sets S(m1), S(m2), S(m3), and S(m4), the spectra in the
frequency domain were first generated as shown in Figure S1c, with 524,289 data points
covering a frequency range from 0 to 250 kHz, corresponding a sample rate of 5 MHz
time domain. The phase for the mth data point of a peak was calculated using

phase(m) =

π
π
(m − mstart ) −
(m − mstart )2 + φ ,m ∈[mstart ,mend ]
2
2N

Equation 2.19

where mstart and mend are the sequence numbers of the start and end data point of a peak,
and ϕ is the initial phase of the data set (with a reference to the ion excitation). For the four
data sets generated, the initial phase ϕ was selected as 0, π/3, π/2, π. A reverse Fourier
transforms was then applied to the process data set to generate a data set in time domain
with 1, 048, 576 data points.
A RF of 580 kHz and 188 Vpp was used for the measurement and a sampling rate of 5
MHz with a resolution of 5 Hz was used. The secular frequencies of protonated cocaine
ion m/z 304 and protonated atenolol ion m/z 267 under these conditions were 123.88 kHz
and 145.04 kHz, respectively. The ratio of the relative intensities of these two ions was
10:7. Four data sets, S(m1), S(m2), S(m3) and S(m4), were generated for 200 ms image
current measurements with different initial phases at 0, π/3,π/2 and π but all with a same
WGN at an SNR of -25 dB (SpNpR = 2.2 and 1.8 for peaks at m/z 304 and 267, respectively).
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2.4! Result and discussion
2.4.1! Broadband MS analysis
Through a broadband excitation and a subsequent image current measurement, ions in
a wide m/z range can be detected simultaneously. In the simulated data sets, S(m1), S(m2),
S(m3) and S(m4), the original peak ratio Rreal for protonated cocaine to atenolol was 1.42.
Applying SC once to S(m1) (Figure 2.3a) with S(m2) (Figure 2.3b), the SC1 spectrum in
frequency domain was obtained after Fourier transform as shown in Figure 3c. In
comparison with the spectra obtained from original data sets (insets in Figure 3a and 3b),
the peaks can be much better observed in the SC1 spectrum (Figure 2.3c). The SpNpR has
been increased from 1.9 to 3.5 for atenolol (m/z 267 at 145.04 kHz) and from 2.5 to 5.7 for
cocaine (m/z 304 at 123.40 kHz). After SC was applied for additional two times with data
set S(m3) and S(m4), future improvements in SpNpR were obtained (Figure 2.3d) with SpNpR
= 29.8 for atenolol and 83.3 for cocaine. The SpNpR as a function of times of applying SC
is plotted for cocaine and atenolol in Figure 2.3e.
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Figure 2.3 Data set S(m1) (a) and S(m2) (b) with two signals at 123.88 kHz and 145.04
kHz, -25 dB white noise in time domain (c) SC1 spectrum obtained after applying SC
with S(m1) and S(m2); (d) SC2 spectrum obtained after further applying SC with S(m3). (e)
Improvement of the SpNpR for protonated cocaine ion m/z 304 at 123.88 kHz and
atenolol ion m/z 267 at 145.04 kHz as a function of times of applying SC. (f) The
improvement of accuracy for peak intensity ratio.
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As discussed above, the preservation of the peak ratios or relative intensities is
important for quantitation. The impact of applying SC on the peak ratios has also been
evaluated. The peak ratio Re was calculated with the observed intensities each time after
applying the SC method, which are 1.25, 1.33, 1.36 and 1.37 for SC1, SC2, SC3 and SC4
spectra, respectively. As shown in Figure 3f, the accuracy of the peak ratio Pr increased
from below 85% for the original spectrum to above 95% for the SC4 spectrum. The
observed intensity of each peak in a spectrum is the summation of the intensities of the
noise and the real signal. The improvement of the SNR through the SC method hence leads
to more accurate peak ratios calculated based on the observed peak intensities.

2.4.2! Selected ion monitoring
In the selected ion monitoring mode, the abundance of ions at a particular m/z value
or the intensities of peaks within a narrow range of frequency are monitored. This can be
applied for the selected reaction monitoring (SRM) for monitoring a specific fragment or
reaction product ion. Since the m/z value and the corresponding frequency of the ion to
be monitored are known, a “mask” data set can be generated for to perform a selective
correlation of the original data sets.
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Figure 2.4 (a) Data set S(m1) with two signals at 123.88 and 145.04 kHz for protonated
cocaine m/z 304 and atenolol m/z 267,with -25 dB white noise in time domain; (b) Mask
data set with signals of equal intensities at 123.81, 145.04, and 150.55 kHz. (c) SC1
spectrum for monitoring selected ions by applying SC with the mask data set and S(m1).
(d) SC4 spectrum obtained by applying SC to the mask dataset with S(m1), S(m2), S(m3)
and S(m4) (e) Spectrum of a simulated data with -40dB WGN and (f) SC4 spectrum
obtained after applying SC to the mask data set with three data sets.

As an example, the simulated data S(m1) for image current measurement (Figure 2.4a)
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is correlated with a mask data (Figure 2.4b). The mask data set is designed for a
simultaneous monitoring of protonated atenolol m/z 267 and cocaine m/z 304 under the
experimental conditions described above. The mask data set contains frequency
components with equal amplitudes of 100 at 123.81 kHz and 145.04 kHz for sampling
signals of ions at m/z 267 and m/z 304, respectively (inset in Figure 2.4b). A third frequency
component at 150.55 kHz (corresponding to m/z 260) is used to sample the noise, with an
assumption that there are no analyte ions at m/z 260. Applying the SC to the mask data set
with the simulated image current data set S(m1) (Figure 2.4a), an SC1 spectrum was
obtained after FFT as shown in Figure 4c. In comparison with the original spectrum (inset
in Figure 2.4a), the SpNpR was much improved after the data processing.
The peak at the 150.55 kHz serves as the indicator for the noise level in the processed
spectrum, which decreased from 100 in the original mask spectrum to 15 in the SC1
spectrum. Further reduction of the noise was achieved by applying SC with additional data
sets S(m2), S(m3) and S(m4), and the noise level was reduced to 2.7. The peak ratios and
their accuracies were also calculated and a trend of the Pr was similar to that shown in
Figure 2.3f.
As a demonstration of the capability of applying SC with the mask data set for selected
ion monitoring, four data sets similar to S(m1), S(m2), S(m3) and S(m4), but all with a much
lower SNR of -40dB were generated for the data processing. A spectrum for one of the
original data set is shown in Figure 2.4e, in which no peak can be observed due to the poor
SNR. After applying SC to the mask data set 4 times with the four data sets, a spectrum
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with significantly improved SpNpR was obtained as shown in Figure 2.4f. The accuracy of
the peak ratio was calculated as 96.7% for the SC4 spectrum.

2.4.3! Intra-SC using a single data set
In addition to applying the SC with multiple data sets collected at different times, the
effectiveness of applying SC to multiple subsets extracted from a single long data set was
also explored. The S(m1) data set for 200 ms image current measurement was equally
divided into multiple subsets for testing the data processing using SC. The SC1 spectrum
with 2 subsets (from one equal division of S(m1)) and the SC9 spectrum with 10 subsets
(from 9 equal division) are shown in Figure 2.5a and Figure 2.5b, respectively. A
significantly better SpNpR was obtained for the SC9 spectrum. The SpNpR and the peak
ratio accuracy are plotted as functions of the number of subsets from equal divisions of
S(m1). While the SpNpR increases monotonically with the number of the divisions (Figure
2.5c), the peak ratio accuracy has been shown to be the best with three subsets divided
from the original data (Figure 2.5d). The optimal number of the divisions of a data set is
expected to be dependent on the SNR and overall length of the original data set, but not
necessarily related to the number of the signal components in the data set.
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Figure 2.5 (a)SC1 spectrum with two data subsets from S(m1). (b) SC9 spectrum obtained
by dividing S(m1) into 10 subsets. (c) Improvement of the SpNpR for protonated cocaine
m/z 304 at 123.81 kHz and atenolol m/z 267 at 145.04 kHz and (d) the variation of the
accuracy in the peak intensity ratio as a function of the number of the data subsets.
Splitting a long data set into subsets theoretically can result in a poorer resolution in
the processed spectrum, since the FFT is applied with a shorter processed data set. As an
example, the limit of the spectral resolution in frequency domain changes from 5 Hz to 50
Hz when a 200 ms data set is split into 10 subsets. However, in a real case where the peak
broadening is mainly due to other factors, such as space charge effect, no significant
broadening due to the shortening of the data set for FFT may be observed.
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2.5! Conclusion
The signal enhancement using self-correlation method has been proposed for
processing random phase signals in Fourier Transform Mass Spectrometry. It is performed
by correlating two sets of signals to identify the similar pattern and to generate a new data
set with the identified pattern of reduced random noise. The SC method can be used in nontargeted, broad band and wide mass range ion detection as well as the targeted ion detection.
The improvements in the signal-to-noise ratio and the peak ratio accuracy have been
demonstrated. Though data sets of equal lengths were used for discussion in this paper, the
SC method can also be applied among data sets of different lengths using the same
procedures. The noise in the longer data set is expected to have more impact on the
processed data than the noise in the shorter ones. The data simulated based on the ion trap
FTMS were used for the characterization of SC method in this study; however, the general
concept and the methods of implementation should apply for data acquired by FT-ICR or
Orbitrap instruments.
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CHAPTER 3.! STATISTICAL ANALYSIS MODEL OF CLASSIFYING STEREO
STRUCTURES OF OLIGOSACCHARIDES USING TANDEM MASS
SPECTROMETRY— AN EXAMPLE OF USING POWER NORMALIZATION
FOR MASS SPECTROMETRY DATA ANALYSIS AND ANALYTICAL
METHOD ASSESSMENT

3.1! Introduction
Oligosaccharides, associated with lipids and proteins, play an important role in the
biological systems such as construction of plasma membrane, cell signaling and cell-cell
recognition1,2. Thus, an increasing interest has been put into the study of the structure of
the oligosaccharides including linkage, anomeric configuration and sugar type. Mass
spectrometry with ability of providing detailed molecular information and high sensitivity
has been generally used in study of sample identification. Associated with tandem mass
spectrometry (MSn), the difference of structure can be revealed in the difference fragment
pattern of diagnostic ion.
Identification of oligosaccharides has difficulty in the highly repetitive unit with
similar mass over charge ratio (m/z). Previous study shows that structure information,
including non-reducing sugar type and anomeric configuration of oligosaccharides, can be
identified by ion trap collision-induced dissociation (CID) with controlled collision
energy3,4. D-aldohexose-glycolaldehydes (GA, Figure 3.1a) of 16 types has been
synthesized for comparison. Accordingly, sugars (e.g. disaccharides, Figure 3.1d) with 16
different non-reducing ends and anomeric configuration (α-D-all, β-D-all, α-D-alt, β-D-
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alt, α-D-gal, β-D-gal, α-D-glc, glc-β-D-glc, α-D-glu, β-D-glu, α-D-ido, β-D-ido, α-D-man,
β-D-man, α-D-tal, β-D-tal) can potentially be classified by the fragment pattern (Figure
3.1c) from diagnostic ion (diagnostic ions m/z 221, C8H13O7-, Figure 3.1b)3,4. Glycobonds of oligosaccharides are highly sensitive to the collision energy input, thus, for each
time, the collision energy should be adjusted to acquire to same ratio of base product ion/
precursor ion. 3,4 The whole process is time-consuming and labor intensive.
(a)$
(b)$

(c)$

(d)$

Figure 3.1 (a) One example of synthesized standards α-D-Glcp-GA. (b) Diagnostic ion
m/z 221 is used as parent ion of fragment patter (c) in classification. (d) One example of
ionized disaccharides α-D-Glcp-(1-4)-D-Glc, m/z 341. Diagnostic ion can be got after
CID.
There are many commercially available or published tools for interpreting mass
spectra data of carbohydrates or mass spectra-based biomarker identification.5
Commercially available databases and libraries6-8, self-synthesized standards3,4 and
extensive publications provide references to match the experiment mass spectra to specific
species.
In the matching process, conventional software of carbohydrates9-12, proteomics13,14
and metabolomics15 justify the structure or identity of a sample based on the existence or
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absence of a set of characteristic peaks. Algorithm of peak matching is one of them, which
counts a set of unique peaks between sample spectra and all reference spectra with certain
tolerance and ranks the counting score to make a judgment (one algorithm of peak
matching11 is shown in Equation 3.5).
On the other hand, intensity-based techniques, which include both intensity and massover-charge ratio of peaks, can improve identification accuracy due to intensity-structure
relation has been considered16,17. Statistical methods such as standard deviation18, t-test19
and ANOVA20 can be used to perform intensity-based peak-level identification, in which
peaks should be pre-selected for analysis. Recently, peak profile has been used for sample
classification and biomarker identification by using pattern recognition methods or
machine learning methods, for example dot product21, principal component analysis
(PCA)22, supporting vector machine (SVM)23, decision tree24 and neural networks25. Due
the profile analysis contains all the mass spectra information including existences,
intensities or the relative intensities in the mass spectra, it receives prospective results and
simplifies the procedure in peak-by-peak analysis.
Profiling-based sample classification and biomarker identification are dependent on the
significance set for the peaks in the statistical methods. Typically higher weights are given
to peaks of higher-intensities, which thereby make them of higher contribution to the final
decision16,26,27.

In analysis of complex samples, the major peaks of the potential

biomarkers, however, can be suppressed by the chemical noise due to other compounds in
the sample matrix and their intensities can be of relatively low levels. Its negative impact
on data analysis is typically avoided by pre-selecting the mass range for the peaks of
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interest based on previous knowledge. This, however, can introduce errors for the data
analysis due to the bias.
In this study, we explored a method for performing a systematic evaluation of the mass
spectrometry data for sample classification and biomarker identification. The outcome can
also be used to assess and optimize the analytical approach at an early stage of a study. A
distinct feature of this method was the power normalization of the peak intensities prior to
the sample classification, which was done using SVM in this study. Power nominalization
index (PNI, to be further described) was varied to systematically rescale the intensities of
all the peaks and the subsequent impacts on the sample classification were analyzed. We
also introduced the error-PNI count plot, which revealed the relationship between the
power normalization and the errors in sample classification and more importantly, served
as a high level summary of the possibility in distinguishing the samples using the particular
analytical procedure.
The nature of the samples and the quality of the data can vary significantly at different
stages of a study. For example, at the early-stage of the study a major aim typically is to
develop and optimize the analytical method that can deliver high quality spectra for
efficient sample classifications. At this stage, the number of biological samples can be
limited and adequate knowledge about the samples might not be available to allow an
arbitrary selection of peaks or mass ranges for data analysis without a significant bias. Data
analysis providing a comprehensive evaluation of the experimental method is particularly
important for the rapid and effective development and optimization of the analytical
method, which can then be used for analysis of biological samples of a large quantity.
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The statistic model can not only use to classify oligosaccharides based on the fragment
pattern of the non-reducing end has been proposed, but also can be used to guide the
method development for biomarker identification at early stage using mass spectrometry.
In addition to the evaluation of early-stage experiment, based on the PN-SVM results, the
possibility of experiment selection of characteristic peaks, ranking of similarity,
comparison between different methods and the effect of experimentally energy control in
data analysis are discussed as well.

3.2! Method
In order to process the mass spectra efficiently, each mass spectrum was converted
into a vector of multiple dimensions, with each dimension corresponding to a particular
mass-to-charge ratio (m/z) with a magnitude assigned as the peak intensity at the m/z value.
The power normalization was applied for each spectrum first, at a PNI value, and the mass
spectra for each sample category were then divided into the training and testing groups.
The classification was done using a multi-class SVM (support vector machine). The
training groups were used to generate the model with classification boundaries, while the
testing group was used to evaluate the classification accuracy using the model. The SVM
method has been shown to be powerful in classifications with lower number of samples28,
which is particularly suitable for early-stage studies with limited number of samples
involved. The testing results can then be used to construct the error-PNI count maps.
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3.2.1! Multi-class SVM
SVM projects the training data into a high dimension space which a maximum-margin
hyper-plane can be found to classify two groups, then projects the testing data on the same
space to predict the label (group) of the sample based on the position relative the hyperplane (Figure 3.2). For classifying 16 types of oligosaccharides, a “one-against-one” multiclass SVM is required to differentiate each two classes29.(Equation 3.1)
min

1
(ω )T ω ij + C ∑ (ξ ij )t
2 ij
t

subject to

(ω ij )T φ (xt ) + bij ≥ 1− ξ ij,t , if x t in the ith class,

ω ij ,bij ,ξij

(ω ij )T φ (xt ) + bij ≤ 1+ ξ ij,t , if x t in the jth class,

ξ ij,t ≥ 0
Equation 3.1
where ω is the normal vector of the hyperplane, i and j represent ith or jth class in the multiclass classification problem, C is a regularization parameter which is typically set as 1 for
oligosaccharides data, t indicates tth sample data, ξ is a slack variable which measures the
misclassification of trainings which ideally equals 0, b is the intercept or offset of the
boundary,φ(x) projects the data into the high dimensions and is a part of the kernel function
that meaures the similarity. Different kernel functions are tested with 16 stardards including
linear kernel, polynomial kernel, radial basis kernel and sigmoid kernel. No obvious
difference is observed which may due to the limitation of data and the data quality.
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Figure 3.2 Workflow of oligosaccharides classification using SVM. Each spectrum is
converted to a vector after prepossessing. The vector is mapped into a high dimension
space, where a classification boundary is generated using the maximum margin by
training data.
3.2.1.1! Decision scores of classification --sum of distance
Decision score is calculated to rank the similarity of the unknown sample to all the
possible sample types. Conventionally, it is calculated by the sum of voting between each
two groups. During this process, the sample type which is more similar to the unknown
will be voted as “+1” and the type getting the highest vote will be considered as predicted
group of the test data. Thus, each testing data will undergo k(k-1)/2 times of pairwise binary
classification process based on decision value (Figure 3.2), where k is the number of the
categories.
While with number of groups goes up to 3, the voting ranking remains a problem. For
example, in the study, there are 16 different kinds of sugars, which means only 16 voting
process is related to the expected group among all the 120 times of voting (16*(16-1)/2).

51
As a result, the irrelevant group may be voted even higher than the expected one. Here, we
use sum of distance to calculate the decision score for different samples. Simply, it is
calculated using the sum of distances (D, the decision score) between the testing sample
and all the classification boundaries for different sample types. This works particularly well
for evaluating the initial analysis in an early-stage study, where the number of possible
sample types is typically larger than the replicates of each sample type.
The distance dij of tth tested sample between the ith and jth group types was calculated
as
dij =

ω ij ⋅ φ (xt ) − bij
ω ij
Equation 3.2

where ω is the normal vector of the hyperplane. The larger is the distance, the further is the
data point away from the classification boundary, which means a higher possibility for
correct assignment of the sample to the corresponding group. The numerator [ωijφ(xt)-bij]
in Equation 3.2 is called the decision value. Sometimes, ranking might be achieved by
simply using ωijφ(xt).30 However, it can only be done in this way when the number of
sample types is limited and properties of training set are similar enough, so b and |ω| can
be ignored.
The sum of the distance Dtm of the tth tested sample for mth sample type was calculated
as

Dtm =

∑

j, if i=m

dij −

∑

dij , i < j, m = 1, 2,..., n

i, if j=m

Equation 3.3
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where n is the total number of the sample types in the classification. The calculated decision
values D can be used to support a variety of data analysis, such as the similarity ranking of
all the possible sample types for testing sample as well as the ranking of the characteristic
peaks that contribute the most to the classification.

3.2.1.2! Ranking of similarity and selecting characteristic peaks
Ranking similarity is simply ranking the decision score in Equation 3.3. For example,
in carbohydrate study, there will be 16 decision values corresponding to 16 possible groups
for the test sample. The group with the highest decision value is considered as the one that
is most similar to the unknown.
The normal vector ω (Equation 3.1) is the coefficient of the mathematical combination
of all the elements in the vector transformed from mass spectra. It is calculated to draw a
classification boundary to largely separate different groups in the nearby area. Thus, the
procedure of finding characteristic peaks is to find the largest coefficients is the ω, which
contributes most in calculating the classification boundary. Choosing different kernel
function may result in different ranking of characteristic peaks. However, when the number
of training sets is very small compared to the dimension of input spectra vectors, the
difference can be ignored.
3.2.2! Power normalization
The power normalization was used to adjust the weights of the peaks at different
intensity levels for the classification. It was performed by scaling the intensity of all the
peaks in the mass spectra with a power normalization index (PNI) (Equation 3.4),
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Peaki = (

peaki

∑ peak

2

) PNI

i

Equation 3.4
where peaki is the original peak intensity of the ith peak in the spectra and Peaki is the scaled
intensity after the power normalization. The denominator, the square root of the sum of
squares of all the peak intensities, was used so to achieve an energy balance in every
spectrum. As shown in Figure 3.3, the normalization at a PNI changed the relative
difference in contribution to classification between peaks of high and low intensities.
Normalization with a PNI lower than 1 reduced the difference, while granting higher
weights to the peaks of lower intensities. For example, the fragment patterns in the MS/MS
spectra (Figure 3.3c, d) recorded for two synthesized monosaccharaides3,4, ido-α-GA and
glc-β-GA, were very simliar. After rescaling the spectra with a power normalization at PNI
of 0.3, the peaks previously hidden now stood out (Figure 3.3a, b). A further analysis using
SVM identified that these peaks originally of low intensities made critical contribution in
distinguishing ido-α-GA and glc-β-GA (to be further discussed later).
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Figure 3.3. Mass spectra of ido-α-GA(a) and glc-β-GA(b) normalized with power index
0.3. The original mass spetra of ido-α-GA(c) and glc-β-GA(d) before power
normalization. (e) The weighing factor of different intensities with different power index.
3.2.3! Other techniques
Peak matching counts the number of peaks with same m/z value of two spectra. The
higher the score is, the more similar the two spectra are. There is no standard formula for
peak matching, formula chosen is from Reference11.
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∑ [1− ( P − P
Peak-maching Score =
n

s

1

r

/ Err)]

ninput

× 100
Equation 3.5

where Ps is the m/z of input peak, Pr is the m/z of reference peak in the library, Err is
the tolerance (in mDa) and n is the number of input peak. Peak matching considers only
the information of present peaks without intensity, thus it may be sensitive to the spectra
quality.
Similarity score and dot product have similar mechanism. It treats each spectrum as
an n-dimension vector, where n is the number of m/z value considered. The score is
calculated based on the cosine angle of two vectors. Similarity score scales the value
between 0 to 1 by calculating the ratio between geometric mean and the arithmetic mean
of corresponding intensities of two spectra (Equation 3.6).
Similarity Score =

I )0.5
,k =
kI s,i + I r ,i

∑ (kI
∑

s,i r ,i

2

∑I
∑I

r ,i
s,i

Equation 3.6
where Is,i is the peak intensity of the ith m/z value in the sample spectra, Ir,i is the peak
intensity in the reference spectra (library or training). k is the normalization term that is
related to the sum of all the peaks intensities the spectra.
Besides, principle component analysis (PCA) is another most frequently used
classification tool, which calculates orthogonal transformation to project the spectra data
into a direction with the largest variance. It is good as a feature filterer by selecting only
the largest components and also as a preliminary step to view the classification for limited
groups of samples with relatively data quality.
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The data analysis is using software Matlab (version R2012b, MathWorks, Natick, MA,
USA). Prepossessing and power normalization are self-written packages; PCA analysis is
done by build-in PCA function in Matlab package; similarity score and peak matching are
self written according to the Equation 3.5 and Equation 3.6.
SVM training and testing are accomplished by online available packages32. Function
of picking characteristic peaks analysis, ranking of similarity and plotting figures are selfwritten code based on the intermediate variable in SVM model.
3.3! Material and mass spectrometry
D-aldohexose-glycolaldehydes (GA, Figure 3.1a) of 16 types has been synthesized
including 8 sugar types and two anomeric configurations (α-D-all, β-D-all, α-D-alt, β-Dalt, α-D-gal, β-D-gal, α-D-glc, β-D-glc, α-D-glu, β-D-glu, α-D-ido, β-D-ido, α-D-man, βD-man, α-D-tal, β-D-tal).
Disaccharides with 18 types and 6 different non-reducing ends are purchased from
Sigma-Aldrich, Inc. (St. Louis, MO, USA) or Carbosynth, Ltd. (Berkshire, UK). The 18
disaccharides are α-D-Galp-(1–3)-D-Gal, α-D-Galp-(1–4)-D-Gal, β-D-Galp-(1–4)-D-Gal ,
β-D-Galp-(1–4)-D-Man, α-D-Galp-(1–6)-D-Glc, α-D-Glcp-(1–2)-D-Glc, β-D-Glcp-(1–2)D-Glc, α-D-Glcp-(1–3)-D-fru, α-D-Glcp-(1–3)-D-Glc, β-D-Glcp-(1–3)-D-Glc, α-D-Glcp(1–4)-D-Glc, β-D-Glcp-(1–4)-D-Glc, α-D-Glcp-(1–6)-D-Glc, β-D-Glcp-(1–6)-D-Glc, αD-Manp-(1–2)-D-Man, α-D-Manp-(1–3)-D-Man, α-D-Manp-(1–4)-D-Man, β-D-Manp(1–4)-D-Glc. More information of the use of material and instrumentation can also be
found in reference [3].
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MS2 CID of deprotonated standards (m/z 221) ion (Figure 3.1b) and MS3 CID of
diagnostic (m/z 221) ion from disaccharides were collected using ion trap CID on
4000QTRAPinstrument (Applied Biosystems/ SCIEX, Concord, Ontario, Canada) as
explained previously.2a In order to avoid space charge effects, the parent ion intensity
before CID was kept around 1 x 106 counts per second (cps). The remaining parent ion
intensity after CID was kept around 18 ± 5% relative to its base product ion (100%) to
obtain reproducible spectra.

3.4! Data groups
Well-controlled data sets with 16 types (7 mass spectra each) are used as standards
(reference) for peak matching and similarity score and training groups for SVM. 156 noncontrolled sugar-GAs and 125 disaccharides are used as the testing for all the four
classification methods.
For a fair comparison with other classification techniques, all the data has the same
prepossessing which regulates m/z input from 1 to 350, which is the m/z range of the raw
data, and the step size as 1. PCA and peak matching has the same normalization method
which set the maximum to 100. Similarity score uses its own sum-based normalization
method that has been discussed below.

3.5! Result and discussion
When the spectra of a sample in a testing group were power-normalized and classified
using SVM, the sample was assigned to a category based on the ranking of the decision
scores. The times of wrong assignments could then be counted for each PNI value and used
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to plot an error-PNI curve as part of the error-PNI count plot. This method was applied for
classifying 16 types of sugar.
(a)(

(b)(

alt$α$GA(

ido$α$GA(

(c)(

(d)(

glu$β$GA(

glc$β$GA(

Figure 3.4 Mass spectra of four types of D-aldohexose-glycolaldehydes, including (a)
alt-α-GA, (b)ido-α-GA, (c) glu-β-GA, and (d)glc-β-GA. Comparing the four types of
sugar, they share the same fragment peaks, but with different intensity.
3.5.1! Error-PNI count plot
The original mass spectra of the carbohydrates share the same dominant peaks with
slight difference in intensity (Figure 3.4). In the application, the error-PNI plot is drawn in
Figure 3.5 chosen with PNIs ranges from 0 to 1 (originally calculated from 0 to 2, chosen
0 to 1 for illustration). Each color and style indicates one type of sugar. Most sugars have
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a valley-shaped curve with a minimum value of 0 (zero error in classification) indicating
the possibility of classifying them from each other based on the mass spectra.
all.α
all.β
alt.α
alt.β
gal.α
gal.β
glc.α
glc.β
gul.α
gul.β
ido.α
ido.β
man.α
man.β
tal.α
tal.β

60

Error>Count>(100%)

50

1

40

2

30
20
10

0
0.1

0.2

0.3

0.4 0.5 0.6 0.7 0.8
Power>Normalization>Index

0.9

1

1.1

Figure 3.5 Error-PNI plot of 16 types of synthesized monosaccharides-GA. Sugar allα is not plotted because no classification error is found along all the PNI. Choosing
different power index at location ① and ② can result in optimized result for
classification of glc-β & tal-β and gul-β & ido-α, respectively.
It is obvious that the selection of the PNI value has a significant impact on the accuracy
in classification. For 14 out of 16 sugars (except for tal-β and ido-α), the assignment is
improved as the PNI increases and can be achieved with 100% accuracy when PNI is larger
than 0.5. However, for tal-β and ido-α a 100% accuracy could only be obtained when the
PNI is lower than 0.5 and 0.34, respectively. This indicates that the dominant fragment
peaks of the diagnostic ions from these two sugars are not related to the structural
differences while the peaks of minor intensities are and therefore can be used as biomarkers
for distinguishing them from other stereoisomers.
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The error-PNI plot as shown in Figure 3.5 represents a summary of a systematic
evaluation of the effectiveness of the experimental approach applied for classifying the
chemical or biological system. The valley in each curve indicates the best normalization
point for classifying each individual component in the chemical system; the overlap of the
valleys, if existing, indicates the best normalization point for the global classification of
the chemical system.
There is no overlap of optimum index for all the sugars. However, the most
overlapping valley of most sugars is located near PNI value of 0.5 instead of 1, which is a
power index applied on the peaks results in no changes to the original value. On the other
hand, due to the similarity score has an inner scaled factor in the numerator, which is
equivalent to the effect of a PNI value of 0.5 (Equation 3.6), it has better classification
accuracy of sugar samples than any other classification methods. However, due to different
samples may have different optimum power index for analysis, the error-PNI plot can help
to find the optimum power index and further to enable a multi-step analysis which will be
discussed later.
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Figure 3.6 (a) PCA of 4 types of highly misclassified sugars with PNI 0.5. (b) PCA of the
same sugars without power normalization (PNI 1)
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The effect of using an appropriate PNI to classify the data can also be illustrated with
the impact on the PCA results. Using classification of all-α, alt-β, gal-α and man-β as an
example, Figure 3.6 shows the PCA results based on the original data and normalized data
with PNI of 0.5, respectively. Without the normalization, all-α, alt-β, gal-α and man-β
could not be clearly distinguished (Figure 3.5a); however, after the normalization at PNI
0.5, the data points for each sample can be much better grouped (Figure 3.5b). This is
because an emphasis on the spectral peaks of lower intensities increases the difference
between the spectra from different types of samples in the classification. This also indicates
that the peaks of the highest intensities in the mass spectra for these samples might not be
used as the signature peaks for distinguishing these samples.
3.5.2! Multi-step analysis —an optimization of classification accuracy
Using the SVM-PNI method involving the CID of the diagnostic ions for classifying
the sugars mentioned above, normalization at PNI between 0.3 and 0.34 (① in Figure 3.5)
should be selected to distinguish glc-β and tal-β, but 0.43 to 0.58 should be selected for
gul-β and ido-α (② in Figure 3.5). Based on the error-PNI plot for the chemical system
with the 16 sugars, it can be predicted that a complete classification cannot be done with a
single step using the current analytical method, since there is not an overlap of all the
valleys of the error-PNI curves. The best overall result for a single step classification would
be obtained with a PNI between 0.46 and 0.56, where 15 of 16 isomers can be classified
correctly. However, based on the error-PNI plot, a multi-step classification can be
suggested to further improve the classification. For instance, in order to achieve a complete
classification, at the first step a PNI = 0.5 (① in Figure 3.5) can be selected to classify all
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15 GAs except for tal-β; at the 2nd step, a PNI =3.2 can be selected to classify tal-β and glcβ (② in Figure 3.5).

3.5.3! Similarity ranking
Similarity ranking ranks the decision value of all the data groups based on the testing
sample (see Section 3.2.1.2). After applying SVM classification with the original spectra
and the normalized spectra at PNI 0.5, the similarity rankings for ido-α are shown in Figure
3.7, respectively. The ranking was based on the sum of distance D (Figure 3.2 and Equation
3.3 )between the testing samples and the classification boundaries (Figure 3.7 inset).
Without the power normalization, the ido-α sample was wrongfully assigned as glc-β, as
shown in Figure 3.7a, which can be corrected by normalization with proper PNI (Figure
3.7b).
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Figure 3.7 Similarity ranking based on distance value for testing sample ido-α (a) without
and (b) with a power normalization at PNI 0f 0.5. Inset in panel (a) and (b) shows the
boundary figure of three top-ranked types.
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3.5.4! Biomarker identification
The normal vector ω (in Equation 3.1 and Equation 3.2) of the corresponding PNI in
the classification can be used to select the characteristic peaks for each sample type. The
peaks with the highest ω value contribute the most in terms of distinguishing the sample
from others. Using the distinction between the glc-α and alt-β samples as an example, the
top 10 candidate peaks ranked for the decision-making are m/z 99, 159, 131, 129, 161, 83,
177, 98, 221 and 87 ((Table 3.1).). 7 out of 10 of the characteristic peaks matches to the
selection which is proposed for all the sugars3. Noticing that the difference in characteristic
peaks between experienced selection and PNI-SVM is mostly the ranking order, which is
the weighing factor of peaks in the accurate classification, this may be another reason why
classification of oligosaccharides is a challenge.
Table 3.1 Characteristic peaks found by SVM compared to experienced selection
st
nd
rd
th
th
th
st
nd
rd
st
1
2
3
4
5
6
7
8
9
10
Experienced 87 99 101 113 129 131 159 161 203 221
selection
PNI-SVM 99 159 131 129 161 83 177 98 221 87
Similarly, comparing the loading plots with and without power normalization of
sample ido-α and glc-β (Figure 3.8), the data analysis with power normalization identified
some peaks, such as m/z 71 and 141, which were not previously selected3 as the signature
peaks but actually can contribute to the distinction between the ido-α and glc-β and samples.

64
(a)#

(b)#

161#

87#
161#
87#
71#

163#

101#

60#

110#
131#

160#
159#

210#

260#

310#
313#

350#

60#

110# 160# 210# 260# 310#
313# 350#

m/z#

159#

m/z#

117#
141#

Figure 3.8 Loading plot of PNI-SVM to classify the two highly similar sample groups
ido-α and glc-β (a) without and (b) with power normalization at PNI of 0.5.
3.5.5! Controlled and non-controlled mass spectra—an evaluation of critical
experimental conditions
Another capability enabled by the analysis with the error-PNI plots is the evaluation
of the critical experimental conditions. In previous studies,3,4 it has been claimed that the
CID conditions, viz. the precursor ion intensity kept at 18 ± 5% relative to the base product
ion after CID,4 was critical for using the diagnostic ions m/z 221 to identify the correct
anomeric configurations. To test the need of retaining this condition for the analysis when
the data analysis with spectral power nomination, we collected additional 132 MS/MS
spectra (Table 3.2) without carefully tuning the CID condition as described above. The
variation of the intensity ratio between the precursor ion and base product ion was in a
range of 24% - 100%. The SVM model was still trained using the 136 data sets collected
under the controlled CID condition. The classification of the 132 samples yielded a 100%
accuracy(Table 3.3).
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Table 3.2 Quantity of 16 types of sugars in controlled and non-controlled condition.
Condition
Controlled data
Non-controlled data
Total
Identity
all-α
7
10
17
all-β
8
9
17
alt-α
8
9
17
alt-β
7
10
17
gal-α
12
4
16
gal-β
8
10
18
glc-α
10
6
16
glc-β
10
6
16
gul-α
7
10
17
gul-β
9
8
17
ido-α
11
6
17
ido-β
9
7
16
man-α
7
10
17
man-β
7
10
17
tal-α
7
9
16
tal-β
9
8
17
Total
136
132
268

Table 3.3 Accuracy of classification of SVM and similarity score.
Test Data
Standards
Disaccharides
Controlled
Non-controlled
Controlled
Non-controlled
Method
data
data
data
data
SVM
135/136
132/132
65/66
59/59
3.5.6! Comparison of classification algorithms
Four algorithms PCA, peak ranking, similarity score and SVM are compared (Figure
3.9). Due to fact that PNI-SVM is the profile-based analysis and has training process to
filter out irrelevant peaks, it has the best performance in analyzing low quantity samples
with large data volume with noisy background and matrix effect, which is usually the
situation in early stage experiment of biomarker identification.
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(a)$

(b)$

(c)$

(d)$

Figure 3.9 (a) PCA score plot of all the 16 types of synthesized standards. Circled area is
where PCA fails to classify. (b) Rank of peak-matching score of the synthesized standard
β-D-altp-GA. Result shows that very similar matching scores may appear for similar
samples. (c) One example, similarity score plot of test data α-D-Glcp-(1-4)-D-Glc. Result
shows that it is not ideal for noisy data, which characteristics are buried with irrelevant
peaks. (d) Distance value plot of test sample α-D-Glcp-(1-4)-D-Glc with boundary figure
of top three ranking types at right top.
In Figure 3.9a, only 3 out of 16 types of sugar can be clearly classified on the twodirection map of PCA score plot with 112 well-controlled standards of 16 types. Because
of the mechanism of PCA is to calculate largest variances among each instance, it has high
possibilities to ignore the important peaks to some degree. Thus, the outliers will largely
distort the projection map and same problem may also arise if groups classified have both
very similar groups and distinct groups.
For each testing spectra, peak matching ranks the matching score of each standard
group. Example shows one ranking histogram of well-controlled standard β-D-altp-GA
(Figure 3.9b). Due to peak matching is matching the number of similar peaks without
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intensity information, the matching score may be too similar to have statistical significance
to classify the groups. Thus, Extra assistance in matching spectra may be needed, for
example experienced annotation, which is labor-intensive.

(a)$

(b)$

Figure 3.10 (a) Averaged standard data of sugar type β-D-Glc (b) one example of noisy
data of disaccharides β-D-Glcp-(1-6)-D-Glc which similarity score fails to detect.
Due to inner scalar 0.5 applied (see Section 3.5.1), the similarity score performs as
well as PNI-SVM, which has classification accuracy approaching 100%. The ranking result
of one example of disaccharide data α-D-Glc-(1-4)-D-Glc (Figure 3.10) by similarity score
and SVM has been shown in Figure 3.9c and Figure 3.9d, respectively. In this case,
similarity score fails in classification, where the correct group is only ranked as the third
with the highest score lowered than 0.8, which indicate the high noise level of the original
mass spectra (Figure 3.10). A boundary figure with three top ranking groups is presented
to show the classification result of PNI-SVM (Figure 3.9d top). Because of the training
process of SVM has the ability to filter out the noisy peaks, the classification result remains
correct.
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3.6! Conclusion
In the study, power normalization with SVM for classifying oligosaccharides based
on the sugar type and anomeric configuration of non-reducing end has been proposed.
Depending on the shape and relative position of the error-PNI curves, the best PNIs can be
selected to classify samples with lower error due to the intensity of biomarker peaks is
weighted more to contribute to the classification. Based on the optimum PNI, characteristic
peaks can be selected and similarity ranking can be performed. Also, a multi-step model
has been introduced to further increase the classification accuracy by choosing different
PNIs for classifying different types of sugars.
By comparison with other classification algorithms for mass spectrometry with noisy
background and highly similar peaks, the result shows that finding the PNI distribution can
highly increase the classification efficiency and the method is ideal for guiding biomarker
identification and sample classification for data with high volume, low data quantity and
high matrix effect, especially in the early stage study. Though, the model parameter is
optimized for oligosaccharides, however the general concept and procedures of
implementation can be used to efficiently guide and evaluate the possibility of biomarker
identification and sample classification for any other mass spectra-based biomarker study.
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CHAPTER 4.! RELEVANCE ANAYSIS— AN INFORMATICS APPROACH FOR
SYSTEMATIC EVALUATION AND GUIDANCE OF METHOD
DEVELOPMENT FOR BIOMATKER IDENTIFICATION IN EARLY-STAGE
STUDY USING MASS SPECTROMETRY

4.1! Introduction
Classification based on mass spectrometry (MS) analysis has been widely practiced in
biological

studies,

including

proteomics,1-5

disease

diagonosis,6-10

bacteria

identifications,11,12 structure analysis of carbohydrates13,14, and etc. The general approach
is to extract the characteristic features from the mass spectra to distinguish different types
of samples. This can be done as simple as by observing a single peak, but in most of the
cases a unique set of multiple peaks needs to be used in the data analysis. Those peaks
represent the existence of a set of chemical or biological compounds of different
concentrations. The classification based on the set of unique peaks can be done using peak
correlation or matching3,4,15, which counts the identical peaks between samples and library,
and statistical methods, such as standard deviation6, t-test8 and ANOVA16, which are
mostly used in proteomics and metabolomics2,17,18 to determine the identity of a sample.19,20
The distinction between the samples often could not be simply based on the existence of
the peaks in the spectra, but also their absolute or relative concentrations, which therefore
the unique profiles of a set of compounds are used for the sample classification and
biomarker identification. Pattern recognition methods or machine learning methods have
been used for this purpose, such as the dot product21, principal component analysis(PCA)12,
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supporting vector machine (SVM)22,23, decision tree24 and neural networks25. Analysis of
peak profiles extracts the information from the mass spectra in a way very different from
the peak-by-peak analysis approaches19,20 and can also comprehensively reveal different
aspects of the samples.
Classification and biomarker identification by peak profiles are dependent on the
significance of peaks included in the mass spectra, thereby peaks with high intensities
weight more in the classification19,26,27. In analysis of complex samples or in early stage
study, however, characteristic peaks are mostly suppressed by sample matrix and their
intensities can be of relatively low levels and not stable compared to the matrix effect. It
lowers the classification accuracy and induces bias when pre-selecting of the mass range
is performed.
Power normalization is a systematical and efficient method to evaluate the possibility
of all the peaks of being biomarkers with less bias on their intensities. It uses Power
nominalization index (PNI) to rescale the intensities of all the peaks and uses error-PNI
count plot to find optimized classification result. It serves as a unique but effective tool
facilitate a comprehensive analysis of the data, which ultimately a reflection of the
analytical approach adopted for the biological study.
Based on power normalization, in this study, we explored relevance analysis to further
assist sample classification. It analyzes the relation between the classification preference
and the original groups at all PNIs and uses the relation to establish multi-step analysis and
estimate probability of sample identity. A distinct feature of this method is the relevance
analysis enables to find out the regular systematic errors in classification and further
increase the classification based on the trend of classification result. Data from three
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experimental studies6,8,12 previously reported were used for the development and validation
of this method.
'
4.2! Method For Data Processing and Analysis
In order to process mass spectrum efficiently, each mass spectrum is converted into a
vector, which each dimension is a particular m/z value and the value of the each element
is the intensity of the peak in the corresponding dimension (m/z). In the study, each
spectrum is applies with power normalization first, then mass spectra in each category are
divided into training and testing groups, which training is used to generate classification
boundary (model) and testing is used to evaluate the model performance (classification
accuracy). The classification is done by multi-class SVM at each PNI. The SVM method
has been shown to be powerful in classifications with lower number of samples28, which is
particularly suitable for early-stage studies with limited number of samples involved. The
testing results can then be used to construct the error-PNI count maps.

4.2.1! Multi-class SVM and decision scores
Multi-class SVM analysis of data after the power normalization has been used to
evaluate the impact by the selection of PNI for the sample classification (see Chapter 3.2.1)
The decision score was calculated using the sum of distances (D) between the testing
sample and all the classification boundaries for different sample types. This works
particularly well for testing of the initial analysis in an early-stage study, where the number
of possible sample types is typically larger than the replicates of each sample type The
distance dij of tth tested sample between the ith and jth group types was calculated as
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dij =

ω ij ⋅ φ (xt ) − bij
ω ij
Equation 4.1

where ω is the normal vector of the hyperplane. The larger is the distance, the further is the
sample away from the classification boundary, which means a higher possibility for correct
assignment to the corresponding group.
The sum of the distance Dtm of the tth tested sample for mth sample type was calculated
as

Dtm =

∑

j, if i=m

dij −

∑

dij , i < j, m = 1, 2,..., n

i, if j=m

Equation 4.2
where n is the total number of the sample types in the classification. The calculated decision
values D can be used to support a variety of data analysis, such as the similarity ranking of
all the possible sample types for a sample tested and the ranking of the characteristic peaks
(biomarkers) which contribute the most to the classification.

4.2.2! Power Normalization
The power normalization was used to adjust the relative contribution of peaks of
different intensities in the decision value of classification. It is performed by scaling the
intensity of all the peaks in the mass spectra with a power normalization index (PNI,
Equation 4.3) to generate normalized mass spectra.

Peaki = (

peaki

∑ peak

2

) PNI

i

Equation 4.3
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where peaki is the original peak intensity of the ith peak in the spectra and Peaki is the scaled
intensity after the power normalization. The denominator, the square root of the sum of
squares of all the peak intensities, was used so to achieve an energy balance in every
spectrum. A PNI lower than 1 decreases the difference in relative intensities, thereby,
increases the weighing factor of the peaks with lower intensities.
The data analysis is using software Matlab (version R2012b, MathWorks, Natick, MA,
USA). The packages available online29 were used to perform SVM. Other functions
including relevance analysis and error analysis were programed based on the output
variable in the SVM model.

4.3! Result and Discussion
Data sets from four previously reported studies were adopted in this study to test and
validate the method described above, including lipid profiles of eighteen types of
bacteria,12 and peptides in human blood samples from patients with melanoma6 and breast
cancer.30 These data sets were all recorded in early-stage studies, where new analytical
methods were developed for potential distention of the samples of different types. The
number of samples for each type is relatively low and conditions for experimental control
might vary significantly.
4.3.1! Multistep analysis by error-PNI plot using Bacteria data
In a previous study, low temperature plasma was used to perform a direct analysis of
bacteria12, including bsubtilis, E. coli K12, SAR A19, SAR A1, SAR A20, SAR A2, SAR
A30, SAR A47, SAR A48, SAR A49, SAR A50, SAR A51 and SAR A63, all in the Luria-
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Ber- tani (LB) agar. As for a typical early-stage study, the study included limited sample
quantity, viz. five spectra for each of 16 bacteria types, and the spectra were subjected to
high matrix effects. For the testing of the classification, one sample of each bacteria was
randomly selected as the testing sample and the rest were used for training. As shown in
Figure 4a and b, while peaks in the m/z range above 200 attribute to fatty acid ethyl esters
from the bacteria membrane, there are abundant peaks in the lower m/z range due to the
sample matrices. Applying the classification method with power normalization, the effect
of pre-selecting a mass range can be systematically analyzed and a clear strategy for
classification can be derived.
Error-PNI plot is a relation between the frequency of classification errors and the PNI
assigned to normalize the mass spectra. As stated before, if the analyzed mass spectra can
be used for biomarker identification, the curve in the plot will show a trend with gradually
lowered valley, where the overlapping valleys for different data groups indicates the best
PNI used to classify the data groups. This is because the PNIs in the overlapping range
emphasizes the characteristic peaks to distinguish different data groups, and then, due to
the difference among mass spectra is enlarged, the data groups can be classified by SVM
with lower error. Thus, with the help of error-PNI plot, evaluation of biomarker
identification can be based on the curve shape and relative positions of error-PNI plots;
and finding biomarkers is a process to find the minimum point on the curve.
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Figure 4.1. Mass spectra of (a) SAR A50 and (b) SAR A51. The blue square is the location
of mass range selection in the previous study. Error-PNI plots (c) without and (d) with mass
range selection.
The error-PNI plot for classification without pre-selecting the m/z range is shown in
Figure 4.1c, with the error-PNI curves highlighted for four types, SAR A50, SAR A2, SAR
A47 and SAR A51, which are highly similar in terms of the lipid profiles in the mass
spectra12 and could not be well distinguished (Figure 4.1a and b, Figure 4.2a). Obviously
there is a difficulty in classifying these samples, with no overlap of the valleys in the errorPNI curves (Figure 4.1c). With the m/z range 250-300 pre-selected, the possibility for
correct classifications is significantly improved (Figure 4.1d). At PNI at 0.7 (① in Figure
4.1d), 15 of 16 bacteria can be correctly classified, except for SAR A47, which can be
correctly classified without power normalization (PNI = 1, at ② in Figure 4.1d). Based
on these results, a two-step procedure shall be used for the classification of all the bacteria
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using SVM, with the first step based on the original data followed by a 2nd step applying
power normalization at PNI of 0.7.
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Figure 4.2. PCA of 14 types of bacteria data. (a) PCA plot with experienced mass
range selection to eliminate the matrix effect. (b) PCA plot without mass range selection.

4.3.2! Relevance profile in multi-step analysis using Melanoma
Similar error analysis was performed to classification of different stages of melanoma.
In the previous study,6 serum samples from B16 mouse model were used to detect the
pulmonary metastatic melanoma. Samples were collected at four different time points,
before the injection of the melanoma cells (day 0), and on day 7, 14 and 21 after the
injection (Figure 4.3). On-chip fraction was used followed by positive mode MALDI-TOF
analysis of the peptides. Thirty samples were collected for each stage. For the classification
in this study, one sample was randomly chosen for the testing and the rest 29 samples were
used for training in SVM. The PNI range was 0.01 to 2, at a step size of 0.05.
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Figure 4.3. Averaged mass spectra of melanoma with developmental stage (a) 0 day
(b) 7 day (c) 14 day and (d) 21 day.
The error-PNI plot for the data analysis is shown in Figure 4.4a. The samples collected
on day 7, day 14 and day 21 can be distinguished from each other at a relatively high
confidence, when using SVM classifications with normalization at PNI between 0.46 and
0.51; however, the error for classifying the cancer stage at day 0 can be as high as nearly
30%. The assignments of the day 0 samples are summarized in Figure 4.4b, with about
15% misclassified as “day 7” and 15% as “day 14”. The “day 0” and “day 21” samples,
however, can be distinguished from each other very well at PNI 0.5.
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Figure 4.4. (a) Error-PNI plot of classification of melanoma samples. (b)
Classification result of the “0 day” samples.
The misclassification of “day 0” samples can be systematically analyzed over the
entire PNI range and the result is shown in Figure 4.5. At a PNI of 0.1, a very few of “0
day” samples are misclassified as “day 7” or “day 14” but not as “day 14”. At a PNI larger
than 0.3, “day 0” samples can be completely distinguished from “day 21” samples but not
from “day 14” or “day 21”. Thus, when selecting certain PNIs, some data group will
invariably be classified as some other groups. This trend is due to the weighing of some
peaks in the testing groups happens to fit the characteristics of the other group. Thus, the
trend of classification errors when sweeping PNIs is the relevance of different sample
groups, which can be further used to increase classification accuracy.
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Figure 4.5. Relevance analysis of the original “0 day” samples. Sample count is the
total number of samples that classified as the corresponding groups. It describes the
classification result of the original “0 day” sample at different PNIs.
The plot in Figure 4.5is termed as the “relevance profile” for the “day 0” samples,
which reveals the relevance between the “day 0” samples and any of the other types of
samples. This type of analysis is extremely useful for selecting the strategy and using the
proper power normalization to distinguish the target sample type (here the “day 0”) from
any other types at the highest confidence.

4.3.3! Error source profile and probability estimation using Breast Cancer
In another study, peptides circulating in blood, which were cleaved by
carboxypeptidase N in the tumor microenvironment, were collected and analyzed in order
to identify the developmental stages of breast cancer.8 Circulating peptides in 58 human
plasma samples have been profiled using MALDI-TOF MS, including 10 samples of
healthy controls (Control), 11 samples with stage I (BC-I), 12 samples with stage II (BCII), 15 samples with stage III (BC-III) and 10 samples with stage IV (BC-IV) breast cancer.
Each sample had two replicates. For testing the SVM with power normalization in this
study, one sample of each type was randomly chosen for testing and the rest were used for
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training in SVM. The PNI was selected from 0.01 to 2 with a step size of 0.05. The samples
were extracted from serum and high matrix effects were observed (Figure 4.6). The errorPNI plot (Figure 4.7) indicates a high possibility of error if the original data (PNI = 1) were
used directly for classification.
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Figure 4.6. High variation of breast cancer data
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As discussed above, a thorough analysis at a system level can be done to understand
a complicated situation in this case. In addition to the relevance profile used above, error
source profile can also be used to summarize the misclassification of other sample types
into one particular type, as shown in Figure 4.8a for the Control sample type. According to
the error source profile, no BC-I is misclassified as Control at all PNIs. At PNI around 0.4,
all the samples classified as Control are true control samples but at PNI 0.8 nearly 10% of
the classified Control are actually Stage II and 2% are Stag IV. As the PNI changes, the
classification components change accordingly.
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Figure 4.8 (a) Error source profile of Ctrl. It describes the original categories of the
predicted Ctrl samples at different PNI. (b) Error source profile of BC-IV
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Probability estimation can be provided by combining classification results at different
PNIs of an unknown sample, based on the relevance and error source profiles. Using a
simple case for an example, if one sample is classified as BC-IV at PNI 0.4 but classified
as Control at PNI 0.8, its true identity can be estimated with a probability. The number of
samples of each type mis-assigned to BC-IV at PNI 0.4 and to Control at PNI 0.8 can be
extracted from the error source profiles of BC-IV and Control types (Figure 4.8b), as listed
in Table 1. The possibility of the said sample to actually be a Control type sample but
being mis-assigned as the BC-IV can be calculated as pctrl=(32/52)(16/52), where 52 is the
total number of the sample.

The possibility for being a BC-II samples is pBC-II =

(2/52)(25/52). Most likely, this sample would not be BC-I, BC-III or BC-IV based on the
information listed in the table. When a sample is determined to be a Control type based on
the classification using the data analysis reported here, the probabilities of its being a true
Control type are calculated as Pctrl = pctrl/(pctrl+pBC-II) = 92% . There is an 8% possibility
for its being a BC-II type sample. SVM with power normalization at multiple PNI values
enables a comprehensive analysis of the data that can assist the process of finding the
ultimate solution in the classification. The information on the mis-assignments can be used
for the sample classification as well.
Table 1. Numbers of samples of each type assigned as BCIV at PNI 0.4 and as Control at PNI 0.8 (total 52 samples).
PNI
PNI 0.4
PNI 0.8
Classified as
BC-IV
Ctrl
Sample Type
Ctrl
32
16
BC-I
25
0
BC-II
24
2
BC-III
29
0
BC-IV
46
0
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One interesting observation is that even though the unknown sample has not been
classified as BC-II at either PNI mentioned, there is probability of the sample to be a BCII. It is because the classification relation between BC-II and BC-IV at some PNIs. In
another word, the sample mass spectrum is more similar to BC-IV when it is normalized
with certain PNI. Obtaining the classification result of more PNIs may improve the
probability estimation due to more information from relevance file can be used. Taking 26
data sets of BC-IV for example, choosing PNI from 0.5 to 2 with step size 0.5, the
probability estimated of being BC-IV are larger than 45% in the 25 out of 26 samples.
Besides BC-IV, some samples also have higher probability as Ctrl and BC-II. It may due
to the classification based on histology is not perfectly corresponded to the molecular-level
change which is detected in the Mass Spectrometry.

4.4! Conclusion
In the study, relevance analysis including multistep analysis, relevance profile and
error source profile is proposed to efficiently evaluate sample classification and estimate
sample identity with low sample quantity, high data volume and high matrix effect
especially at early stage study. The selection of multiple proper normalization factors
enables multistep analysis with higher classification accuracy while the analysis of
relevance profile is performed. Based on relation of classification preference at all PNIs,
error source profile were introduced to facilitate a comprehensive analysis of the sample
identity by find the classification probability, which is performed by finding all the
misclassified or regular error pair.Its applications in data analysis for the studies involving
spectra for bacteria, melanoma and breast cancer samples have been demonstrated and
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multi-dimension data analysis enabled by the power normalization at various PNI values
could be used to improve the sample classification significantly.
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